Robertson, MM. The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 2: Tentative explanations for differing prevalence figures in GTS, including the possible effects of psychopathology, aetiology, cultural differences, and differing phenotypes. J Psychosom Res 2008;65:473–86.Google Scholar

Tourette Syndrome Classification Study Group. Definitions and classification of tic disorders. Arch Neurol 1993;50:1013–16.Google Scholar

Woods, DW, Thomsen, PH. Tourette and tic disorders in ICD-11: Standing at the diagnostic crossroads. Rev Bras Psiquiatr 2014;36(Suppl 1):51–8.Google Scholar

Belluscio, BA, Tinaz, S, Hallett, M. Similarities and differences between normal urges and the urge to tic. Cogn Neurosci 2011;2:245–6.Google Scholar

Bliss, J, Cohen, DJ, Freedman, DX. Sensory experiences of Gilles de la Tourette syndrome. Arch Gen Psychiatr 1980;37:1343–7.Google Scholar

Cavanna, AE, Black, KJ, Hallett, M, Voon, V. Neurobiology of the premonitory urge in Tourette syndrome: Pathophysiology and treatment implications. J Neuropsychiatr Clin Neurosci 2017;29:95–104.Google Scholar

Cavanna, AE, Nani, A. Tourette syndrome and consciousness of action. Tremor Other Hyperkinetic Mov 2013;3:181.Google Scholar

Conceição, VA, Dias, Â, Farinha, AC, Maia, TV. Premonitory urges and tics in Tourette syndrome: Computational mechanisms and neural correlates. Curr Opin Neurobiol 2017;46:187–99.Google Scholar

Cox, JH, Seri, S, Cavanna, AE. Sensory aspects of Tourette syndrome. Neurosci Biobehav Rev 2018;88:170–6.Google Scholar

Ganos, C, Hummel, FC. My urge, my tic: A missing link between urges and tic inhibition. Cogn Neurosci 2011;2:249–50.Google Scholar

Ganos, C, Rothwell, J, Haggard, P. Voluntary inhibitory motor control over involuntary tic movements. Mov Disord 2018;33:937–46.Google Scholar

Houghton, DC, Capriotti, MR, Conelea, CA, Woods, DW. Sensory phenomena in Tourette syndrome: Their role in symptom formation and treatment. Curr Dev Disord Rep 2014;1:245–51.Google Scholar

Jackson, GM, Draper, A, Dyke, K, Pépés, SE, Jackson, SR. Inhibition, disinhibition and the control of action in Tourette syndrome. Trends Cogn Sci 2015;19:655–65.Google Scholar

Jackson, SR, Parkinson, A, Kim, SY, Schuermann, M, Eickhoff, SB. On the functional anatomy of the urge-for-action. Cogn Neurosci 2011;2:227–57.Google Scholar

Kane, MJ. Premonitory urges as “attentional tics” in Tourette’s syndrome. J Am Acad Child Adolesc Psychiatr 1994;33:805–8.Google Scholar

Kranick, SM, Hallett, M. Neurology of volition. Exp Brain Res 2013;229:313–27.Google Scholar

Patel, N, Jankovic, J, Hallett, M. Sensory aspects of movement disorders. Lancet Neurol 2014;13:100–12.Google Scholar

Prado, HS, Rosário, MC, Lee, J, Hounie, AG, Shavitt, RG, Miguel, EC. Sensory phenomena in obsessive-compulsive disorder and tic disorders: A review of the literature. CNS Spectrums 2008;13:425–32.Google Scholar

Rae, CL, Critchley, HD, Seth, AK. A Bayesian account of the sensory-motor interactions underlying symptoms of Tourette syndrome. Frontiers Psychiatr 2019;10:29.Google Scholar

Aldred, M, Cavanna, AE. Tourette syndrome and socioeconomic status. Neurol Sci 2015;36:1643–9.Google Scholar

Bloch, MH, Panza, KE, Landeros-Weisenberger, A, Leckman, JF. Meta-analysis: Treatment of attention-deficit hyperactivity disorder in children with comorbid tic disorders. J Am Acad Child Adolesc Psychiatr 2009;48:884–93.Google Scholar

Cavanna, AE, Eddy, C, Rickards, H. Cognitive functioning in Tourette syndrome. Disc Med 2009;8:191–5.Google Scholar

Cavanna, AE, Martino, D. How many Gilles de la Tourette syndromes? Eur J Neurol 2014;21:685–6.Google Scholar

Cavanna, AE, Servo, S, Monaco, F, Robertson, MM. The behavioral spectrum of Gilles de la Tourette syndrome. J Neuropsychiatr Clin Neurosci 2009;21:13–23.Google Scholar

Cavanna, AE. Gilles de la Tourette syndrome as a paradigmatic neuropsychiatric disorder. CNS Spectr 2018;23:213–18.Google Scholar

Cavanna, AE. The neuropsychiatry of Gilles de la Tourette syndrome: The état de l’art. Rev Neurol 2018;174:621–7.Google Scholar

Como, PG, LaMarsh, J, O’Brien, KA. Obsessive-compulsive disorder in Tourette’s syndrome. Adv Neurol 2005;96:249–61.Google Scholar

Cox, JH, Nahar, A, Termine, C, Agosti, M, Balottin, U, Seri, S, Cavanna, AE. Social stigma and self-perception in adolescents with Tourette syndrome. Adolesc Health Med Therapeutics 2019;10:75–82.Google Scholar

Cravedi, E, Deniau, E, Giannitelli, M, Xavier, J, Hartmann, A, Cohen, D. Tourette syndrome and other neurodevelopmental disorders: A comprehensive review. Child Adolesc Psychiatr Ment Health 2017;11:59.Google Scholar

Eapen, V, Cavanna, AE, Robertson, MM. Co-morbidities, social impact and quality of life in Tourette syndrome. Frontiers Psychiatr 2016;7:97.Google Scholar

El Malhany, N, Gulisano, M, Rizzo, R, Curatolo, P. Tourette syndrome and comorbid ADHD: Causes and consequences. Eur J Pediatr 2014;174:279–88.Google Scholar

Erenberg, G. The relationship between Tourette syndrome, attention deficit hyperactivity disorder, and stimulant medication: A critical review. Semin Pediatr Neurol 2005;12:217–21.Google Scholar

Evans, J, Seri, S, Cavanna, AE. The effects of Gilles de la Tourette syndrome on quality of life across the lifespan: A systematic review. Eur Child Adolesc Psychiatr 2016;25:939–48.Google Scholar

Gagné, JP. The psychology of Tourette disorder: Revisiting the past and moving toward a cognitively-oriented future. Clin Psychol Rev 2019;67:11–21.Google Scholar

Kalyva, E, Kyriazi, M, Vargiami, E, Zafeiriou, D. A review of co-occurrence of autism spectrum disorder and Tourette syndrome. Res Autism Spectr Disord 2016;24:39–51.Google Scholar

Khalifa, N, Von Knorring, AL. Psychopathology in a Swedish population of school children with tic disorders. J Am Acad Child Adolesc Psychiatr 2006;45:1346–53.Google Scholar

Kloft, L, Steinel, T, Kathmann, N. Systematic review of co-occurring OCD and TD: Evidence for a tic-related OCD subtype? Neurosci Biobehav Rev 2018;95:280–314.CrossRef Google Scholar PubMed

Lombroso, PJ, Scahill, L. Tourette syndrome and obsessive-compulsive disorder. Brain Dev 2008;30:231–7.Google Scholar

Martinez-Martin, P. What is quality of life and how do we measure it? Relevance to Parkinson’s disease and movement disorders. Mov Disord 2017;32:382–92.Google Scholar

Perez, DL, Keshavan, MS, Scharf, JM, Boes, AD, Price, BH. Bridging the great divide: What can neurology learn from psychiatry? J Neuropsychiatr Clin Neurosci 2018;30:271–8.Google Scholar

Pringsheim, T, Piacentini, J. Tic-related obsessive-compulsive disorder. J Psychiatr Neurosci 2018;43:431–2.Google Scholar

Rizzo, R, Gulisano, M, Calì, PV, Curatolo, P. Tourette syndrome and comorbid ADHD: Current pharmacological treatment options. Eur J Pediatr Neurol 2013;17:421–8.Google Scholar

Robertson, MM, Cavanna, AE, Eapen, V. Gilles de la Tourette syndrome and disruptive behavior disorders: Prevalence, associations and explanation of the relationships. J Neuropsychiatr Clin Neurosci 2015;26:33–41.Google Scholar

Robertson, MM. Attention deficit hyperactivity disorder, tics and Tourette’s syndrome: The relationship and treatment implications. Eur Child Adolesc Psychiatr 2006;15:1–11.Google Scholar

Robertson, MM. Mood disorders and Gilles de la Tourette’s syndrome: An update on prevalence, etiology, comorbidity, clinical associations, and implications. J Psychosom Res 2006;61:349–58.Google Scholar

Scahill, L, Sukhodolsky, DG, Williams, SK, Leckman, JF. Public health significance of tic disorders and children and adolescents. Adv Neurol 2005;96:240–8.Google Scholar

Silvestri, P, Baglioni, V, Cardona, F, Cavanna, AE. Self-concept and self-esteem in patients with chronic tic disorders: A systematic literature review. Eur J Paediatr Neurol 2018;22:749–56.Google Scholar

Simpson, HA, Jung, L, Murphy, TK. Update on attention-deficit/hyperactivity disorder and tic disorders: A review of the current literature. Curr Psychiatr Rep 2011;13:351–6.Google Scholar

Wright, A, Rickards, H, Cavanna, AE. Impulse control disorders in Gilles de la Tourette syndrome. J Neuropsychiatr Clin Neurosci 2012;24:16–27.Google Scholar

Albin, RL, Mink, JW. Recent advances in Tourette syndrome research. Trends Neurosci 2006;29:175–82.Google Scholar

Albin, RL. Tourette syndrome: A disorder of the social decision-making network. Brain 2018;141:332–47.CrossRef Google Scholar PubMed

Ali, F, Morrison, KE, Cavanna, AE. The complex genetics of Gilles de la Tourette syndrome: Implications for clinical practice. Neuropsychiatry 2013;3:321–30.Google Scholar

Bronfeld, M, Bar-Gad, I. Tic disorders: What happens to the basal ganglia? Neuroscientist 2013;19:101–8.Google Scholar

Cauchi, RJ, Tarnok, Z. Genetic animal models of Tourette syndrome: The long and winding road from lab to clinic. Transl Neurosci 2012;3:153–9.Google Scholar

Cox, JH, Seri, S, Cavanna, AE. Histaminergic modulation in Tourette syndrome. Expert Opinion Orphan Drugs 2016;4:205–13.Google Scholar

Dale, RC. Tics and Tourette: A clinical, pathophysiological and etiological review. Curr Opin Pediatr 2017;29:665–73.CrossRef Google Scholar

Deng, H, Gao, K, Jankovic, J. The genetics of Tourette syndrome. Nat Rev Neurol 2012;8:203–13.Google Scholar

Felling, RJ, Singer, HS. Neurobiology of Tourette syndrome: Current status and need for further investigation. J Neurosci 2011;31:12387–95.Google Scholar

Ganos, C. Tics and Tourette’s: Update on pathophysiology and tic control. Curr Opin Neurol 2016;29:513–18.Google Scholar

Hashemiyoon, R, Kuhn, J, Visser-Vandewalle, V. Putting the pieces together in Gilles de la Tourette syndrome: Exploring the link between clinical observations and the biological basis of dysfunction. Brain Topogr 2017;30:3–29.Google Scholar

Hawksley, J, Cavanna, AE, Nagai, Y. The role of the autonomic nervous system in Tourette syndrome. Frontiers Neurosci 2015;9:117.Google Scholar

Leckman, JF, Bloch, MH, Smith, ME, Larabi, D, Hampson, M. Neurobiological substrates of Tourette’s disorder. J Child Adolesc Psychopharmacol 2010;20:237–47.Google Scholar

Madhusudan, N, Cavanna, AE. The role of immune dysfunction in the development of tics and susceptibility to infections in Tourette syndrome: A systematic review. Basal Ganglia 2013;3:77–84.Google Scholar

Maia, TV, Conceição, VA. Dopaminergic disturbances in Tourette syndrome: An integrative account. Biol Psychiatr 2018;84:332–44.CrossRef Google Scholar PubMed

Martino, D, Ganos, C, Worbe, Y. Neuroimaging applications in Tourette’s syndrome. Int Rev Neurobiol 2018;143:65–108.Google Scholar

Martino, D, Zis, P, Buttiglione, M. The role of immune mechanisms in Tourette syndrome. Brain Res 2015;1617:126–43.Google Scholar

Qi, Y, Zheng, Y, Li, Z, Liu, Z, Xiong, L. Genetic studies of tic disorders and Tourette syndrome. Methods Mol Biol 2019;2011:547–71.Google Scholar

Zapparoli, L, Porta, M, Paulesu, E. The anarchic brain in action: The contribution of task-based fMRI studies to the understanding of Gilles de la Tourette syndrome. Curr Opin Neurol 2015;28:604–11.Google Scholar

Cavanna, AE, Schrag, A, Morley, D, Orth, M, Robertson, MM, Joyce, E, Critchley, HD, Selai, C. The Gilles de la Tourette Syndrome–Quality of Life scale (GTS-QOL): Development and validation. Neurology 2008;71:1410–16.Google Scholar

Chung, SJ, Lee, JS, Yoo, TI, et al. Development of the Korean form of Yale Global Tic Severity Scale: A validity and reliability study. J Korean Neuropsychiatr Assoc 1998;37:942–51.Google Scholar

Cubo, E, Saez Velasco, S, Delgado Benito, V, et al. Validation of screening instruments for neuroepidemiological surveys of tic disorders. Mov Disord 2011;26:520–6.Google Scholar

Gaffney, GR, Sieg, K, Hellings, J. The MOVES: A self-rating scale for Tourette’s syndrome. J Child Adolesc Psychopharmacol 1994;4:269–80.CrossRef Google Scholar

García-López, R, Perea-Milla, E, Romero-Gonzalez, J, et al. Adaptacion al espanol y validez diagnostica de la Yale Global Tics Severity Scale. Rev Neurol 2008;46:261–6.Google Scholar

Gulisano, M, Calì, P, Palermo, F, Robertson, MM, Rizzo, R. Premonitory urges in patients with Gilles de la Tourette syndrome: An Italian translation and a 7-year follow-up. J Child Adolesc Psychopharmacol 2015;25:810–16.Google Scholar

Jalenques, I, Guiguet-Auclair, C, Derost, P, Joubert, P, Foures, L, Hartmann, A, Muellner, J, Rondepierre, F. Syndrome de Gilles de La Tourette Study Group. The MOVES (Motor tic, Obsessions and compulsions, Vocal tic Evaluation Survey): Cross-cultural evaluation of the French version and additional psychometric assessment. J Neurol 2018;265:678–87.Google Scholar

Jeon, S, Walkup, JT, Woods, DW, et al. Detecting a clinically meaningful change in tic severity in Tourette syndrome: A comparison of three methods. Contemp Clin Trials 2013;36:414–20.Google Scholar

Kircanski, K, Woods, DW, Chang, SW, Ricketts, EJ, Piacentini, JC. Cluster analysis of the Yale Global Tic Severity Scale (YGTSS): Symptom dimensions and clinical correlates in an outpatient youth sample. J Abnorm Child Psychol 2010;38:777–88.Google Scholar

Leckman, JF, Riddle, MA, Hardin, MT, et al. The Yale Global Tic Severity Scale: Initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatr 1989;28:566–73.Google Scholar

Leckman, JF, Towbin, KE, Ort, SI, Cohen, DJ. Clinical assessment of tic disorder severity. In: Cohen, DJ, Bruun, RD, Leckman, JF (eds), Tourette’s syndrome and tic disorders: Clinical understanding and treatment. New York: John Wiley, 1988.Google Scholar

Leivonen, S, Voutilainen, A, Hinkka-Yii-Salomaki, S, et al. A nationwide register study of the characteristics, incidence and validity of diagnosed Tourette syndrome and other tic disorders. Acta Paediatr 2014;103:984–90.Google Scholar

Martino, D, Cavanna, AE, Colosimo, C, Hartmann, A, Leckman, JF, Munchau, A, Pringsheim, TM. Systematic review of severity scales and screening instruments for tics: Critique and recommendations. Mov Disord 2017;32:467–73.Google Scholar

McGuire, JF, McBride, N, Piacentini, J, et al. The premonitory urge revisited: An individualized premonitory urge for tics scale. J Psychiatr Res 2016;83:176–83.Google Scholar

McGuire, JF, Piacentini, J, Storch, EA, et al. A multicenter examination and strategic revisions of the Yale Global Tic Severity Scale. Neurology 2018;90:e1711–19.Google Scholar

Pietracupa, S, Bruno, E, Cavanna, AE, Falla, M, Zappia, M, Colosimo, C. Scales for hyperkinetic disorders: A systematic review. J Neurol Sci 2015;358:9–21.Google Scholar

Robertson, MM, Banerjee, S, Kurlan, R, Cohen, DJ, Leckman, JF, McMahon, W, Pauls, DL, Sandor, P, van de Wetering, BJ. The Tourette syndrome diagnostic confidence index: Development and clinical associations. Neurology 1999;53:2108–12.Google Scholar

Shapiro, AK, Shapiro, ES. Controlled study of pimozide vs. placebo in Tourette’s syndrome. J Am Acad Child Psychiatr 1984;23:161–73.Google Scholar

Shytle, RD, Silver, AA, Sheehan, KH, et al. The Tourette’s Disorder Scale (TODS): Development, reliability, and validity. Assessment 2003;10:273–87.CrossRef Google Scholar PubMed

Stefanoff, P, Wolanczyk, T. Validity and reliability of Polish adaptation of Yale Global Tic Severity Scale (YGTSS) in a study of Warsaw schoolchildren aged 12–15. Przegl Epidemiol 2005;59:753–62.Google Scholar

Steinberg, T, Baruch, SS, Harush, A, et al. Tic disorders and the premonitory urge. J Neural Transm 2010;117:277–84.Google Scholar

Storch, EA, De Nadai, AS, Lewin, AB, et al. Defining treatment response in pediatric tic disorders: A signal detection analysis of the Yale Global Tic Severity Scale. J Child Adolesc Psychopharmacol 2011;21:621–7.Google Scholar

Storch, EA, Merlo, LJ, Lehmkuhl, H, et al. Further psychometric examination of the Tourette’s Disorder Scales. Child Psychiatr Hum Dev 2007;38:89–98.Google Scholar

Storch, EA, Murphy, TK, Fernandez, M, et al. Factor-analytic study of the Yale Global Tic Severity Scale. Psychiatr Res 2007;149:231–7.Google Scholar

Storch, EA, Murphy, TK, Geffken, GR, et al. Further psychometric properties of the Tourette’s Disorder Scale-Parent Rated version (TODS-PR). Child Psychiatr Hum Dev 2004;35:107–20.Google Scholar

Storch, EA, Murphy, TK, Geffken, GR, et al. Reliability and validity of the Yale Global Tic Severity Scale. Psychol Assess 2005;17:486–91.Google Scholar

Su, MT, McFarlane, F, Cavanna, AE, Termine, C, Murray, I, Heidemeyer, L, Heyman, I, Murphy, T. The English version of the Gilles de la Tourette Syndrome–Quality of Life Scale for children and adolescents (C&A-GTS-QOL): A validation study in the United Kingdom. J Child Neurol 2017;32:76–83.Google Scholar

Sutherland Owens, AN, Miguel, EC, Swerdlow, NR. Sensory gating scales and premonitory urges in Tourette syndrome. Sci World J 2011;11:736–41.Google Scholar

Walkup, JT, Rosenberg, LA, Brown, J, Singer, HS. The validity of instruments measuring tic severity in Tourette’s syndrome. J Am Acad Child Adolesc Psychiatr 1992;31:472–7.Google Scholar

Wang, S, Qi, F, Li, J, Zhao, L, Li, A. Effects of Chinese herbal medicine Ningdong Granule on regulating dopamine (DA)/serotonin (5-TH) and gamma-aminobutyric acid (GABA) in patients with Tourette syndrome. BioSci Trends 2012;6:212–18.Google Scholar

Woods, DW, Piacentini, J, Himle, MB, Chang, S. Premonitory urge for tics scale (PUTS): Initial psychometric results and examination of the premonitory urge phenomenon in youths with tic disorders. Dev Behav Pediatr 2005;26:397–403.Google Scholar

Accad, M, Francis, D. Does evidence based medicine adversely affect clinical judgment? BMJ 2018;362:k2799.Google Scholar

Ackermans, L, Kuhn, J, Neuner, I, Temel, Y, Visser-Vandewalle, V. Surgery for Tourette syndrome. World Neurosurg 2013;80:e15–22.Google Scholar

Ackermans, L, Temel, Y, Visser-Vandewalle, V. Deep brain stimulation in Tourette’s syndrome. Neurotherapeutics 2008;5:339–44.Google Scholar

Akbarian-Tefaghi, L, Zrinzo, L, Foltynie, T. The use of deep brain stimulation in Tourette syndrome. Brain Sci 2016;6:35.Google Scholar

Akici, A, Oktay, S. Rational pharmacotherapy and pharmacovigilance. Curr Drug Safety 2007;2:65–9.Google Scholar

Baldermann, JC, Schüller, T, Huys, D, Becker, I, Timmermann, L, Jessen, F, Visser-Vandewalle, V, Kuhn, J. Deep brain stimulation for Tourette syndrome: A systematic review and meta-analysis. Brain Stimul 2016;9:296–304.Google Scholar

Bate, KS, Malouff, JM, Thorsteinsson, ET, Bhullar, N. The efficacy of habit reversal therapy for tics, habit disorders, and stuttering: A meta-analytic review. Clin Psychol Rev 2011;31:865–71.Google Scholar

Bennett, SM, Keller, AE, Walkup, JT. The future of tic disorder treatment. Ann N Y Acad Sci 2013;1304:32–9.Google Scholar

Bloch, MH. Emerging treatments for Tourette’s disorder. Curr Psychiatr Rep 2008;10:323–30.Google Scholar

Budman, CL. The role of atypical antipsychotics for treatment of Tourette’s syndrome. Drugs 2014;74:1177–93.Google Scholar

Caprini, G, Melotti, V. Una grave sindrome ticcosa guarita con haloperidol. Rivista Sperimentale di Freniatra 1961;85:191–6.Google Scholar

Cavanna, AE, Eddy, CM, Mitchell, R, Pall, H, Mitchell, I, Zrinzo, L, Foltynie, T, Jahanshahi, M, Limousin, P, Hariz, MI, Rickards, H. An approach to Deep Brain Stimulation for severe treatment-refractory Tourette syndrome: The UK perspective. Br J Neurosurg 2011;25:38–44.Google Scholar

Cavanna, AE, Monaco, F. Placebo treatments: Historical overview and current concepts. Confinia Cephalalgica 2006;15:3–11.Google Scholar

Cavanna, AE, Nani, A. Pharmacological treatment of tics in Gilles de la Tourette syndrome. Clin Manage Issues 2011;5:145–55.Google Scholar

Cavanna, AE, Seri, S. Chronic tic disorders: Diagnosis, treatment and management. Clinical Pharmacist 2016;8:2.Google Scholar

Cavanna, AE, Strigaro, G, Monaco, F. Brain mechanisms underlying the placebo effect in neurological disorders. Funct Neurol 2007;22:89–94.Google Scholar

Cavanna, AE. Back to the future: Stoic wisdom and psychotherapy for neuropsychiatric conditions. Future Neurology 2019;14:1.Google Scholar

Cavanna, AE. Stoic philosophy and psychotherapy: Implications for neuropsychiatric conditions. Dialogues Philos Mental Neuro Sci 2019;12:10–24.Google Scholar

Chadehumbe, MA, Brown, LW. Advances in the treatment of Tourette’s disorder. Curr Psychiatr Rep 2019;21:31.Google Scholar

Chandros, S, Colloca, L, Avins, A, Gordon, NP, Somkin, CP, Kaptchuk, TJ, Miller, FG. Patients’ attitudes about the use of placebo treatments: Telephone survey. BMJ 2013;346:f3757.Google Scholar

Cox, JH, Seri, S, Cavanna, AE. Safety and efficacy of aripiprazole for the treatment of pediatric Tourette syndrome and other chronic tic disorders. Pediatr Health Med Therapeutics 2016;7:57–64.Google Scholar

Cubo, E, González, M, Singer, H, Mahone, EM, Scahill, L, MüllerVahl, KR, et al. Impact of placebo assignment in clinical trials of tic disorders. Mov Disord 2013;28(9):1288–92.Google Scholar

Deeb, W, Malaty, IA, Mathews, CA. Tourette disorder and other tic disorders. Handb Clin Neurol 2019;165:123–53.Google Scholar

Dutta, N, Cavanna, AE. Effectiveness of Habit Reversal Therapy in the treatment of Tourette syndrome and other chronic tic disorders: A systematic review. Funct Neurol 2013;28:7–12.Google Scholar

Eddy, CM, Rickards, HE, Cavanna, AE. Treatment strategies for tics in Tourette syndrome. Therapeutic Adv Neurol Disord 2011;4:25–45.Google Scholar

Evidence Based Medicine Working Group. Evidence based medicine: A new approach to teaching the practice of medicine. JAMA 1992;268:2420–5.Google Scholar

Faria, V, Kossowsky, J, Petkov, MP, Kaptchuk, TJ, Kirsch, I, Lebel, A, Borsook, D. Parental attitudes about placebo use in children. J Pediatr 2017;181:272–8.Google Scholar

Ferreira, JJ, Trenkwalder, C, Mestre, TA. Placebo and nocebo responses in other movement disorders besides Parkinson’s disease: How much do we know? Mov Disord 2018;33:1228–35.Google Scholar

Fraint, A, Pal, G. Deep brain stimulation in Tourette’s syndrome. Frontiers Neurol 2015;6:170.Google Scholar

Fründt, O, Woods, D, Ganos, C. Behavioral therapy for Tourette syndrome and chronic tic disorders. Neurol Clin Pract 2017;7:148–56.Google Scholar

Ganos, C, Martino, D, Pringsheim, T. Tics in the pediatric population: Pragmatic management. Mov Disord Clin Pract 2017;4:160–72.Google Scholar

Gordon, JA. From neurobiology to novel medications: A principled approach to translation. Am J Psychiatr 2019;176:425–7.Google Scholar

Greenhalgh, T, Howick, J, Maskrey, N, Evidence Based Medicine Renaissance Group. Evidence based medicine: A movement in crisis? BMJ 2014;348:g3725.Google Scholar

Grelotti, DJ, Kaptchuk, TJ. Placebo by proxy. BMJ 2011;343:d4345.Google Scholar

Hariz, MI, Robertson, MM. Gilles de la Tourette syndrome and deep brain stimulation. Eur J Neurosci 2010;32:1128–34.Google Scholar

Hartmann, A, Martino, D, Murphy, T. Gilles de la Tourette syndrome: A treatable condition? Rev Neurol 2016;172:446–54.Google Scholar

Huys, D, Hardenacke, K, Poppe, P, Bartch, C, Baskin, B, Kuhn, J. Update on the role of antipsychotics in the treatment of Tourette syndrome. Neuropsychiatric Dis Treatment 2012;8:95–104.Google Scholar

Kermen, R, Hickner, J, Brody, H, Hasham, I. Family physicians believe the placebo effect is therapeutic but often use real drugs as placebos. Fam Med 2010;42:636–42.Google Scholar

Kious, BM, Jimenez-Shahed, J, Shprecher, DR. Treatment-refractory Tourette syndrome. Prog Neuropsychopharmacol Biol Psychiatr 2016;70:227–36.Google Scholar

Kompoliti, K, Fan, W, Leurgans, S. Complementary and alternative medicine use in Gilles de la Tourette syndrome. Mov Disord 2009;24:2015–19.Google Scholar

Kompoliti, K, Goetz, CG, Morrissey, M, Leurgans, S. Gilles de la Tourette syndrome: Patient’s knowledge and concern of adverse effects. Mov Disord 2006;21:248–52.Google Scholar

Koy, A, Lin, J-P, Sanger, TD, Marks, WA, Mink, JW, Timmermann, L. Advances in management of movement disorders in children. Lancet Neurol 2016;15:719–35.Google Scholar

Kurlan, RM. Treatment of Tourette syndrome. Neurotherapeutics 2014;11:161–5.Google Scholar

Ludlow, AK, Rogers, SL. Understanding the impact of diet and nutrition on symptoms of Tourette syndrome: A scoping review. J Child Health Care 2018;22:68–83.Google Scholar

Macerollo, A, Martino, D, Cavanna, AE, Gulisano, M, Hartmann, A, Hoekstra, PJ, Hedderly, T, Debes, NM, Muller-Vahl, K, Neuner, I, Porta, M, Rickards, H, Rizzo, R, Cardona, F, Roessner, V. Refractoriness to pharmacological treatment for tics: A multicenter European audit. J Neurol Sci 2016;366:136–8.Google Scholar

Malaty, IA, Akbar, U. Updates in medical and surgical therapies for Tourette syndrome. Curr Neurol Neurosci Rep 2014;14:458.Google Scholar

Martino, D, Pringsheim, TM. Tourette syndrome and other chronic tic disorders: An update on clinical management. Expert Rev Neurother 2018;12:125–37.Google Scholar

McGuire, JF, Piacentini, J, Brennan, EA, Lewin, AB, Murphy, TK, Small, BJ, Storch, EA. A meta-analysis of behavior therapy for Tourette Syndrome. J Psychiatr Res 2014;50:106–12.Google Scholar

Mink, J, Tourette Syndrome Association. Patient selection and assessment recommendations for deep brain stimulation in Tourette syndrome. Mov Disord 2006;21:1831–8.Google Scholar

Mink, J. Clinical review of DBS for Tourette syndrome. Frontiers Biosci 2009;1:72–6.Google Scholar

Naguy, A. Clonidine use in psychiatry: Panacea or panache? Pharmacology 2016;98:87–92.Google Scholar

Nussey, C, Pistrang, N, Murphy, T. How does psychoeducation help? A review of the effects of providing information about Tourette syndrome and attention-deficit/hyperactivity disorder. Child Care Health Dev 2013;39:617–27.Google Scholar

Pandey, S, Dash, D. Progress in pharmacological and surgical management of Tourette syndrome and other chronic tic disorders. Neurologist 2019;24:93–108.Google Scholar

Piacentini, J, Woods, DW, Scahill, L, Wilhelm, S, Peterson, AL, Chang, S, Ginsburg, GS, Deckersbach, T, Dziura, J, Levi-Pearl, S, Walkup, JT. Behavior therapy for children with Tourette disorder: A randomized controlled trial. JAMA 2010;303:1929–37.Google Scholar

Piedad, JCP, Rickards, H, Cavanna, AE. What patients with Gilles de la Tourette syndrome should be treated with deep brain stimulation and what is the best target? Neurosurgery 2012;71:173–92.Google Scholar PubMed

Porta, M, Menghetti, C, Sassi, M, Brambilla, A, Defendi, S, Servello, D, Selvini, C, Eddy, C, Rickards, H, Cavanna, AE. Treatment-refractory Tourette syndrome. Ital J Psychopathol 2011;17:225–33.Google Scholar

Quezada, J, Coffman, KA. Current approaches and new developments in the pharmacological management of Tourette syndrome. CNS Drugs 2018;32:33–45.Google Scholar

Reese, HE, Timpano, KR, Siev, J, Rowley, T, Wilhelm, S. Behavior therapy for Tourette’s syndrome and chronic tic disorder: A web-based video illustration of treatment components. Cogn Behav Pract 2010;17:16–24.Google Scholar

Rickards, H, Wood, C, Cavanna, AE. Hassler and Dieckmann’s seminal paper on stereotaxic thalamotomy for Gilles de la Tourette syndrome: Translation and critical reappraisal. Mov Disord 2008;23:1966–72.Google Scholar

Roessner, V, Schoenffeld, K, Buse, J, Bender, S, Ehrlich, S, Münchau, A. Pharmacological treatment of tic disorders and Tourette syndrome. Neuropharmacology 2013;68:143–9.Google Scholar

Sackett, DL, Rosenberg, WMC, Gray, JA, Haynes, RB, Richardson, WS. Evidence based medicine: What it is and what it isn’t. BMJ 1996;312:71–2.Google Scholar

Saleh, C, Gonzalez, V, Cif, L, Coubes, P. Deep brain stimulation of the globus pallidus internus and Gilles de la Tourette syndrome: Toward multiple networks modulation. Surg Neurol Int 2012;3(Suppl 2):127–42.Google Scholar

Scahill, L, Erenberg, G, Berlin, CM Jr, Budman, C, Coffey, BJ, Jankovic, J, Kiessling, L, King, RA, Kurlan, R, Lang, A, Mink, J, Murphy, T, Zinner, S, Walkup, J. Contemporary assessment and pharmacotherapy of Tourette syndrome. NeuroRX 2006;3:192–206.Google Scholar

Scahill, L, Woods, DW, Himle, MB, Peterson, AL, Wilhelm, S, Piacentini, JC, McNaught, K, Walkup, JT, Mink, JW. Current controversies on the role of behavior therapy in Tourette syndrome. Mov Disord 2013;28:1179–83.Google Scholar

Scannell, JW, Blanckley, A, Boldon, H, Warrington, B. Diagnosing the decline in pharmaceutical R&D efficiency. Nat Rev Drug Disc 2012;11:191–200.Google Scholar

Schrock, LE, Mink, JW, Woods, DW, Porta, M, Servello, D, Visser-Vandewalle, V, et al. Tourette syndrome deep brain stimulation: A review and updated recommendations. Mov Disord 2015;30:448–71.Google Scholar

Seignot, JN. Un cas de Maladie de Tics de Gilles de la Tourette guéri par le R.1625. Ann Médico-Psychologiques 1961;119:578–9.Google Scholar

Shprecher, D, Kurlan, R. The management of tics. Mov Disord 2009;24:15–24.Google Scholar

Singer, HS. Treatment of tics and Tourette syndrome. Curr Treat Options Neurol 2010;12:539–61.Google Scholar

Srour, M, Lespérance, P, Richer, F, Chouinard, S. Psychopharmacology of tic disorders. J Can Acad Child Adolesc Psychiatr 2008;17:150–9.Google Scholar

Steeves, TD, Fox, SH. Neurobiological basis of serotonin-dopamine antagonists in the treatment of Gilles de la Tourette syndrome. Prog Brain Res 2008;172:495–513.Google Scholar

Thomas, R, Cavanna, AE. The pharmacology of Tourette syndrome. J Neural Transmission 2013;120:689–94.Google Scholar

Viswanathan, A, Jimenez-Shahed, J, Carvallo, JFB, Jankovic, J. Deep brain stimulation for Tourette syndrome: Target selection. Stereotact Funct Neurosurg 2012;90:213–24.Google Scholar

Waddington, JL. Why does the goalkeeper eschew medication? The challenge of new treatments for Tourette syndrome. Mov Disord 2018;33:1236–7.Google Scholar

Waldon, K, Hill, S, Termine, C, Balottin, U, Cavanna, AE. Trials of pharmacological interventions for Tourette syndrome: A systematic review. Behav Neurol 2013;26:265–73.Google Scholar

Wieseler, B, McGauran, N, Kaiser, T. New drugs: Where did we go wrong and what can we do better? BMJ 2019;366:14340.Google Scholar

Wile, DJ, Pringsheim, TM. Behavior therapy for Tourette syndrome: A systematic review and meta-analysis. Curr Treat Options Neurol 2013;15:385–95.Google Scholar

Wilhelm, S, Peterson, AL, Piacentini, J, Woods, DW, Deckersbach, T, Sukhodolsky, DG, Chang, S, Liu, H, Dziura, J, Walkup, JT, Scahill, L. Randomized trial of behavior therapy for adults with Tourette syndrome. Arch Gen Psychiatr 2012;69:795–803.Google Scholar

Young, SL, Taylor, M, Lawrie, SM. ‘First do no harm’: A systematic review of the prevalence and management of antipsychotic adverse effects. J Psychopharmacol 2015;29:353–62.Google Scholar

Cath, DC, Hedderly, T, Ludolph, AG, Stern, JS, Murphy, T, Hartmann, A, Czernecki, V, Robertson, MM, Martino, D, Munchau, A, Rizzo, R, ESSTS Guidelines Group. European clinical guidelines for Tourette syndrome and other tic disorders. Part I: Assessment. Eur Child Adolesc Psychiatr 2011;20:155–71.Google Scholar

Roessner, V, Plessen, KJ, Rothenberger, A, Ludolph, AG, Rizzo, R, Skov, L, Strand, G, Stern, JS, Termine, C, Hoekstra, PJ, ESSTS Guidelines Group. European clinical guidelines for Tourette syndrome and other tic disorders. Part II: Pharmacological treatment. Eur Child Adolesc Psychiatr 2011;20:173–96.Google Scholar

Verdellen, C, van de Griendt, J, Hartmann, A, Murphy, T, ESSTS Guidelines Group. European clinical guidelines for Tourette syndrome and other tic disorders. Part III: Behavioural and psychosocial interventions. Eur Child Adolesc Psychiatr 2011;20:197–207.Google Scholar

Muller-Vahl, KR, Cath, DC, Cavanna, AE, Dehning, S, Porta, M, Robertson, MM, Visser-Vandewalle, V, ESSTS Guidelines Group. European clinical guidelines for Tourette syndrome and other tic disorders. Part IV: Deep brain stimulation. Eur Child Adolesc Psychiatr 2011;20:209–17.Google Scholar

Cavanna, AE, Rickards, H, Worrall, R, Hoekstra, PJ, Plessen, KJ, Roessner, V. From ipse dixit to evidence-based guidelines: On the optimal management of Tourette syndrome. Eur J Paediatr Neurol 2012;16:310–11.Google Scholar

Rickards, H, Cavanna, AE, Worrall, R. Treatment practices in Tourette syndrome: The European perspective. Eur J Paediatr Neurol 2012;16:361–4.Google Scholar

Pringsheim, T, Doja, A, Gorman, D, McKinlay, D, Day, L, Billinghurst, L, Carroll, A, Dion, Y, Luscombe, S, Steeves, T, Sandor, P. Canadian guidelines for the evidence-based treatment of tic disorders: Pharmacotherapy. Can J Psychiatr 2012;57:133–43.Google Scholar

Steeves, T, McKinlay, D, Gorman, D, Billinghurst, L, Day, L, Carroll, A, Dion, Y, Doja, A, Luscombe, S, Sandor, P, Pringsheim, T. Canadian guidelines for the evidence-based treatment of tic disorders: Behavioural therapy, deep brain stimulation and transcranial magnetic stimulation. Can J Psychiatr 2012;57:144–51.Google Scholar

Murphy, TK, Lewin, AB, Storch, EA, Stock, S. Practice parameter for the assessment and treatment of children and adolescents with tic disorders. J Am Acad Child Adolescent Psychiatr 2013;52:1341–59.Google Scholar

Cuenca, J, Glazebrook, C, Kendall, T, Hedderly, T, Heyman, I, Jackson, G, Murphy, T, Rickards, H, Robertson, M, Stern, J, Trayner, P, Hollis, C. Perceptions of treatment for tics among young people with Tourette syndrome and their parents: A mixed methods study. BMC Psychiatr 2015;15:46.Google Scholar

Hollis, C, Pennant, M, Cuenca, J, Glazebrook, C, Kendall, T, Whittington, C, Stockton, S, Larsson, L, Bunton, P, Dobson, S, Groom, M, Hedderly, T, Heyman, I, Jackson, GM, Jackson, S, Murphy, T, Rickards, H, Robertson, M, Stern, J. Clinical effectiveness and patient perspectives of different treatment strategies for tics in children and adolescents with Tourette syndrome: A systematic review and qualitative analysis. Health Technol Assess 2016;20(4).Google Scholar

Whittington, C, Pennant, M, Kendall, T, Glazebrook, C, Trayner, P, Groom, M, Hedderly, T, Heyman, I, Jackson, G, Murphy, T, Rickards, H, Robertson, M, Stern, M, Hollis, C. Treatments for Tourette syndrome in children and young people: A systematic review. J Child Psychol Psychiatr 2016;57:988–1004.Google Scholar

Pringsheim, T, Okun, MS, Muller-Vahl, K, Martino, D, Jankovic, J, Cavanna, AE, Woods, DW, Robinson, M, Jarvie, E, Roessner, V, Oskoui, M, Holler-Managan, Y, Piacentini, J. Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology 2019;92:896–906.Google Scholar

Pringsheim, T, Holler-Managan, Y, Okun, MS, Jankovic, J, Piacentini, J, Cavanna, AE, Martino, D, Muller-Vahl, K, Woods, DW, Robinson, M, Jarvie, E, Roessner, V, Oskoui, M. Comprehensive systematic review summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology 2019;92:907–15.Google Scholar

Hamamoto, Y, Fujio, M, Nonaka, M, Matsuda, N, Kono, T, Kano, Y. Expert consensus on pharmacotherapy for tic disorders in Japan. Brain Develop 2019;41:501–6.Google Scholar

Yang, C, Hao, Z, Zhu, C, Guo, Q, Mu, D, Zhang, L. Interventions for tic disorders: An overview of systematic reviews and meta analyses. Neurosci Biobehav Rev 2016;63:239–55.Google Scholar

Yang, C, Zhang, Z, Zhang, L, Tian, J, Yu, D, Wang, J, Yang, J. Quality assessment of clinical practice guidelines on tic disorders with AGREE II instrument. Psychiatr Res 2018;259:385–91.Google Scholar

American Academy of Neurology. Clinical practice guideline process manual, 2011. St. Paul, MN: American Academy of Neurology, 2011.Google Scholar

Guyatt, GH, Oxman, AD, Vist, GE, et al. GRADE: An emerging consensus on rating quality of evidence and strength or recommendations. Br Med J 2008;336:924–6.Google Scholar

Moher, D, Liberati, A, Tetzlaff, J, Altman, DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med 2009;6(7):e1000097.Google Scholar

Moher, D, Schulz, KF, Simera, I, Altman, DG. Guidance for developers of health research reporting guidelines. PLoS Med 2010;7(2):e1000217.Google Scholar

Elbe, D, Black, TR, McGrane, IR, Procyshyn, RM. Clinical handbook of psychotropic drugs for children and adolescents online. 4th ed. Boston, MA: Hogrefe, 2019.Google Scholar

Schatzberg, AF, DeBattista, C. Schatzberg’s manual of clinical psychopharmacology. 9th ed. Washington, DC: American Psychiatric Association Publishing, 2019.Google Scholar

Silberstein, SD, Marmura, MJ, Yuan, H. Essential neuropharmacology: The prescriber’s guide. 2nd ed. Cambridge: Cambridge University Press, 2015.Google Scholar

Stahl, SM. Stahl’s essential psychopharmacology: Prescriber’s guide. 6th ed. Cambridge: Cambridge University Press, 2018.Google Scholar

Stahl, SM. Stahl’s essential psychopharmacology: Prescriber’s guide – children and adolescents. Cambridge: Cambridge University Press, 2019.Google Scholar

Taylor, DM, Barnes, TRE, Young, AH. The Maudsley prescribing guidelines in psychiatry. 13th ed. Chichester, UK: Wiley-Blackwell, 2018.Google Scholar

Goetz, CG, Klawans, HL. Gilles de la Tourette on Tourette syndrome. Adv Neurol 1982;35:1–16.Google Scholar

Shapiro, AK, Shapiro, E. Tourette syndrome: History and present status. Adv Neurol 1982;35:17–23.Google Scholar

Murray, TJ. Doctor Samuel Johnson’s abnormal movements. Adv Neurol 1982;35:25–30.Google Scholar

Cohen, DJ, Detlor, J, Shaywitz, BA, Leckman, JF. Interaction of biological and psychological factors in the natural history of Tourette syndrome: A paradigm for childhood neuropsychiatric disorders. Adv Neurol 1982;35:31–4.Google Scholar

Welch, KM. Impairment of cerebral serotonin and energy metabolism during ischemia: Relevance to migraine. Adv Neurol 1982;33:35–40.Google Scholar

Nauta, WJ. Limbic innervation of the striatum. Adv Neurol 1982;35:41–7.Google Scholar

Levitt, P. Central monoamine neuron systems: Their organization in the developing and mature primate brain and the genetic regulation of their terminal fields. Adv Neurol 1982;35:49–59.Google Scholar

Pickel, VM, Joh, TH, Reis, DJ, Miller, RJ. Study of enkephalin-containing neurons and dopaminergic afferents in the neostriatum. Adv Neurol 1982;35:61–7.Google Scholar

Iversen, SD, Alpert, JE. Functional organization of the dopamine system in normal and abnormal behavior. Adv Neurol 1982;35:69–76.Google Scholar

Bonnet, KA. Neurobiological dissection of Tourette syndrome: A neurochemical focus on a human neuroanatomical model. Adv Neurol 1982;35:77–82.Google Scholar

Richardson, EP Jr. Neuropathological studies of Tourette syndrome. Adv Neurol 1982;35:83–7.Google Scholar

Sacks, OW. Acquired Tourettism in adult life. Adv Neurol 1982;35:89–92.Google Scholar

Jacobs, BL, Trulson, ME, Heym, J, Steinfels, GF. On the role of CNS serotonin in the motor abnormalities of Tourette syndrome: Behavioral and single-unit studies. Adv Neurol 1982;35:93–8.Google Scholar

Bunney, BS, DeRiemer, S. Effect of clonidine on dopaminergic neuron activity in the substantia nigra: Possible indirect mediation by noradrenergic regulation of the serotonergic raphe system. Adv Neurol 1982;35:99–104.Google Scholar

Obeso, JA, Rothwell, JC, Marsden, CD. The neurophysiology of Tourette syndrome. Adv Neurol 1982;35:105–14.Google Scholar

Domino, EF, Piggott, L, Demetriou, S, Culbert, J. Visually evoked responses in Tourette syndrome. Adv Neurol 1982;35:115–20.Google Scholar

Buck, SH, Yamamura, HI. Neuropeptides in normal and pathological basal ganglia. Adv Neurol 1982;35:121–32.Google Scholar

Friedhoff, AJ. Receptor maturation in pathogenesis and treatment of Tourette syndrome. Adv Neurol 1982;35:133–40.Google Scholar

Stahl, SM, Berger, PA. Cholinergic and dopaminergic mechanisms in Tourette syndrome. Adv Neurol 1982;35:141–50.Google Scholar

Javoy-Agid, F, Ruberg, M, Taquet, H, Studler, JM, Garbarg, M, Llorens, C, Schwartz, JC, Grouselle, D, Lloyd, KG, Raisman, R, Agid, Y. Biochemical neuroanatomy of the human substantia nigra (pars compacta) in normal and Parkinsonian subjects. Adv Neurol 1982;35:151–63.Google Scholar

Walsh, FX, Bird, ED, Stevens, TJ. Monoamine transmitters and their metabolites in the basal ganglia of Huntington’s disease and control postmortem brain. Adv Neurol 1982;35:165–9.Google Scholar

Ang, L, Borison, R, Dysken, M, Davis, JM. Reduced excretion of MHPG in Tourette syndrome. Adv Neurol 1982;35:171–5.Google Scholar

Singer, HS, Tune, LE, Butler, IJ, Zaczek, R, Coyle, JT. Clinical symptomatology, CSF neurotransmitter metabolites, and serum haloperidol levels in Tourette syndrome. Adv Neurol 1982;35:177–83.Google Scholar

Koslow, SH, Cross, CK. Cerebrospinal fluid monoamine metabolites in Tourette syndrome and their neuroendocrine implications. Adv Neurol 1982;35:185–97.Google Scholar

Shaywitz, BA, Wolf, A, Shaywitz, SE, Loomis, R, Cohen, DJ. Animal models of neuropsychiatric disorders and their relevance for Tourette syndrome. Adv Neurol 1982;35:199–202.Google Scholar

Wolfson, L, Brown, LL, Makman, M, Warner, C, Dvorkin, B, Katzman, R. Dopamine mechanisms in the subthalamic nucleus and possible relationship to hemiballismus and other movement disorders. Adv Neurol 1982;35:203–11.Google Scholar

Weiner, WJ, Carvey, P, Nausieda, PA, Goetz, CG, Klawans, HL. Effect of chronic levodopa on haloperidol-induced behavioral supersensitivity in the guinea pig. Adv Neurol 1982;35:213–19.Google Scholar

Diamond, BI, Reyes, MG, Borison, R. A new animal model for Tourette syndrome. Adv Neurol 1982;35:221–5.Google Scholar

Essman, WB, Essman, EJ. Comparative features of an animal model for behavioral and neurochemical change. Adv Neurol 1982;35:227–32.Google Scholar

Knott, PJ, Hutson, PH. Stress-induced stereotypy in the rat: Neuropharmacological similarities to Tourette syndrome. Adv Neurol 1982;35:233–8.Google Scholar

Ruddle, FH. Reverse genetics as a means of understanding and treating genetic disease. Adv Neurol 1982;35:239–42.Google Scholar

Kidd, KK, Pauls, DL. Genetic hypotheses for Tourette syndrome. Adv Neurol 1982;35:243–9.Google Scholar

Comings, DE, Gursey, BT, Hecht, T, Blume, K. HLA typing in Tourette syndrome. Adv Neurol 1982;35:251–3.Google Scholar

Comings, DE, Gursey, BT, Avelino, E, Kopp, U, Hanin, I. Red blood cell choline in Tourette syndrome. Adv Neurol 1982;35:255–8.Google Scholar

Schoenberg, BS. Neuroepidemiologic approach to Tourette syndrome. Adv Neurol 1982;35:259–65.Google Scholar

Lucas, AR, Beard, CM, Rajput, AH, Kurland, LT. Tourette syndrome in Rochester, Minnesota, 1968–1979. Adv Neurol 1982;35:267–9.Google Scholar

Kondo, K, Nomura, Y. Tourette syndrome in Japan: Etiologic considerations based on associated factors and familial clustering. Adv Neurol 1982;35:271–6.Google Scholar

Nomura, Y, Segawa, M. Tourette syndrome in Oriental children: Clinical and pathophysiological considerations. Adv Neurol 1982;35:277–80.Google Scholar

Mak, FL, Chung, SY, Lee, P, Chen, S. Tourette syndrome in the Chinese: A follow-up of 15 cases. Adv Neurol 1982;35:281–3.Google Scholar

Asam, U. A follow-up study of Tourette syndrome. Adv Neurol 1982;35:285–6.Google Scholar

Golden, GS. Tourette syndrome in children: Ethnic and genetic factors and response to stimulant drugs. Adv Neurol 1982;35:287–9.Google Scholar

Nee, LE, Polinsky, RJ, Ebert, MH. Tourette syndrome: Clinical and family studies. Adv Neurol 1982;35:291–5.Google Scholar

Joschko, M, Rourke, BP. Neuropsychological dimensions of Tourette syndrome: Test-retest stability and implications for intervention. Adv Neurol 1982;35:297–304.Google Scholar

Incagnoli, T, Kane, R. Neuropsychological functioning in Tourette syndrome. Adv Neurol 1982;35:305–9.Google Scholar

Sutherland, RJ, Kolb, B, Schoel, WM, Whishaw, IQ, Davies, D. Neuropsychological assessment of children and adults with Tourette syndrome: A comparison with learning disabilities and schizophrenia. Adv Neurol 1982;35:311–22.Google Scholar

Hagin, RA, Beecher, R, Pagano, G, Kreeger, H. Effects of Tourette syndrome on learning. Adv Neurol 1982;35:323–8.Google Scholar

Wilson, RS, Garron, DC, Tanner, CM, Klawans, HL. Behavior disturbance in children with Tourette syndrome. Adv Neurol 1982;35:329–33.Google Scholar

Montgomery, MA, Clayton, PJ, Friedhoff, AJ. Psychiatric illness in Tourette syndrome patients and first-degree relatives. Adv Neurol 1982;35:335–9.Google Scholar

Fahn, S. The clinical spectrum of motor tics. Adv Neurol 1982;35:341–4.Google Scholar

Goetz, CG, Tanner, CM, Klawans, HL. Compressive neuropathies in Tourette syndrome. Adv Neurol 1982;35:345–7.Google Scholar

Fahn, S. A case of post-traumatic tic syndrome. Adv Neurol 1982;35:349–50.Google Scholar

Ludlow, CL, Polinsky, RJ, Caine, ED, Bassich, CJ, Ebert, MH. Language and speech abnormalities in Tourette syndrome. Adv Neurol 1982;35:351–61.Google Scholar

Nuwer, MR. Coprolalia as an organic symptom. Adv Neurol 1982;35:363–8.Google Scholar

van Woert, MH, Rosenbaum, D, Enna, SJ. Overview of pharmacological approaches to therapy for Tourette syndrome. Adv Neurol 1982;35:369–75.Google Scholar

Borison, RL, Ang, L, Chang, S, Dysken, M, Comaty, JE, Davis, JM. New pharmacological approaches in the treatment of Tourette syndrome. Adv Neurol 1982;35:377–82.Google Scholar

Shapiro, AK, Shapiro, E. Clinical efficacy of haloperidol, pimozide, penfluridol, and clonidine in the treatment of Tourette syndrome. Adv Neurol 1982;35:383–6.Google Scholar

Moldofsky, H, Brown, GM. Tics and serum prolactin response to pimozide in Tourette syndrome. Adv Neurol 1982;35:387–90.Google Scholar

Leckman, JF, Cohen, DJ, Detlor, J, Young, JG, Harcherik, D, Shaywitz, BA. Clonidine in the treatment of Tourette syndrome: A review of data. Adv Neurol 1982;35:391–401.Google Scholar

Bruun, RD. Clonidine treatment of Tourette syndrome. Adv Neurol 1982;35:403–5.Google Scholar

Rosenberg, GS, Davis, KL. Precursors of acetylcholine: Considerations underlying their use in Tourette syndrome. Adv Neurol 1982;35:407–12.Google Scholar

Shapiro, E, Shapiro, AK. Tardive dyskinesia and chronic neuroleptic treatment of Tourette patients. Adv Neurol 1982;35:413.Google Scholar

Klawans, HL, Nausieda, PA, Goetz, CC, Tanner, CM, Weiner, WJ. Tourette-like symptoms following chronic neuroleptic therapy. Adv Neurol 1982;35:415–18.Google Scholar

Fog, R, Pakkenberg, H, Regeur, L, Pakkenberg, B. ‘Tardive’ Tourette syndrome in relation to long-term neuroleptic treatment of multiple tics. Adv Neurol 1982;35:419–21.Google Scholar

Rapoport, JL, Nee, L, Mitchell, S, Polinsky, R, Ebert, M. Hyperkinetic syndrome and Tourette syndrome. Adv Neurol 1982;35:423–6.Google Scholar

Bogomolny, A, Erenberg, G, Rothner, AD. Behavioral effects of haloperidol in young Tourette syndrome patients. Adv Neurol 1982;35:427–32.Google Scholar

Bruun, RD. Dysphoric phenomena associated with haloperidol treatment of Tourette syndrome. Adv Neurol 1982;35:433–6.Google Scholar

Caine, ED, Polinsky, RJ, Ludlow, CL, Ebert, MH, Nee, LE. Heterogeneity and variability in Tourette syndrome. Adv Neurol 1982;35:437–42.Google Scholar

Bruun, RD, Budman, CL. The natural history of Tourette syndrome. Adv Neurol 1992;58:1–6.Google Scholar

Jankovic, J. Diagnosis and classification of tics and Tourette syndrome. Adv Neurol 1992;58:7–14.Google Scholar

Leckman, JF, Pauls, DL, Peterson, BS, Riddle, MA, Anderson, GM, Cohen, DJ. Pathogenesis of Tourette syndrome: Clues from the clinical phenotype and natural history. Adv Neurol 1992;58:15–24.Google Scholar

Lang, AE. Clinical phenomenology of tic disorders selected aspects. Adv Neurol 1992;58:25–32.Google Scholar

Cath, DC, Hoogduin, CA, van de Wetering, BJ, van Woerkom, TC, Roos, RA, Rooymans, HG. Tourette syndrome and obsessive-compulsive disorder: An analysis of associated phenomena. Adv Neurol 1992;58:33–41.Google Scholar

Fallon, T Jr, Schwab-Stone, M. Methodology of epidemiological studies of tic disorders and comorbid psychopathology. Adv Neurol 1992;58:43–53.Google Scholar

Earls, F. Psychosocial factors in Tourette syndrome. Adv Neurol 1992;58:55–9.Google Scholar

Apter, A, Pauls, DL, Bleich, A, Zohar, AH, Kron, S, Ratzoni, G, Dycian, A, Kotler, M, Weizman, A, Cohen, DJ. A population-based epidemiological study of Tourette syndrome among adolescents in Israel. Adv Neurol 1992;58:61–5.Google Scholar

Kerbeshian, J, Burd, L. Epidemiology and comorbidity: The North Dakota prevalence studies of Tourette syndrome and other developmental disorders. Adv Neurol 1992;58:67–74.Google Scholar

Kurlan, R. Tourette syndrome in a special education population: Hypotheses. Adv Neurol 1992;58:75–81.Google Scholar

Leonard, HL, Swedo, SE, Rapoport, JL, Rickler, KC, Topol, D, Lee, S, Rettew, D. Tourette syndrome and obsessive-compulsive disorder. Adv Neurol 1992;58:83–93.Google Scholar

Coffey, B, Frazier, J, Chen, S. Comorbidity, Tourette syndrome, and anxiety disorders. Adv Neurol 1992;58:95–104.Google Scholar

Robertson, MM. Self-injurious behavior and Tourette syndrome. Adv Neurol 1992;58:105–14.Google Scholar

Lavoie, B, Côté, PY, Parent, A. Immunohistochemical study of the basal ganglia in normal and parkinsonian monkeys. Adv Neurol 1992;58:115–21.Google Scholar

Anderson, GM, Pollak, ES, Chatterjee, D, Leckman, JF, Riddle, MA, Cohen, DJ. Postmortem analysis of subcortical monoamines and amino acids in Tourette syndrome. Adv Neurol 1992;58:123–33.Google Scholar

Singer, HS. Neurochemical analysis of postmortem cortical and striatal brain tissue in patients with Tourette syndrome. Adv Neurol 1992;58:135–44.Google Scholar

Haber, SN, Wolfer, D. Basal ganglia peptidergic staining in Tourette syndrome: A follow-up study. Adv Neurol 1992;58:145–50.Google Scholar

Pauls, DL. Issues in genetic linkage studies of Tourette syndrome: Phenotypic spectrum and genetic model parameters. Adv Neurol 1992;58:151–7.Google Scholar

McMahon, WM, Leppert, M, Filloux, F, van de Wetering, BJ, Hasstedt, S. Tourette symptoms in 161 related family members. Adv Neurol 1992;58:159–65.Google Scholar

Heutink, P, van de Wetering, BJ, Breedveld, GJ, Oostra, BA. Genetic study on Tourette syndrome in the Netherlands. Adv Neurol 1992;58:167–72.Google Scholar

Wilkie, PJ, Ahmann, PA, Hardacre, J, LaPlant, RJ, Hiner, BC, Weber, JL. Application of microsatellite DNA polymorphisms to linkage mapping of Tourette syndrome gene(s). Adv Neurol 1992;58:173–80.Google Scholar PubMed

Devor, EJ. Linkage studies in 16 St. Louis families: Present status and pursuit of an adjunct strategy. Adv Neurol 1992;58:181–7.Google Scholar

Comings, DE, Comings, BG. Alternative hypotheses on the inheritance of Tourette syndrome. Adv Neurol 1992;58:189–99.Google Scholar

Demeter, S. Structural imaging in Tourette syndrome. Adv Neurol 1992;58:201–6.Google Scholar

Riddle, MA, Rasmusson, AM, Woods, SW, Hoffer, PB. SPECT imaging of cerebral blood flow in Tourette syndrome. Adv Neurol 1992;58:207–11.Google Scholar

Stoetter, B, Braun, AR, Randolph, C, Gernert, J, Carson, RE, Herscovitch, P, Chase, TN. Functional neuroanatomy of Tourette syndrome: Limbic-motor interactions studied with FDG PET. Adv Neurol 1992;58:213–26.Google Scholar

Brooks, DJ, Turjanski, N, Sawle, GV, Playford, ED, Lees, AJ. PET studies on the integrity of the pre and postsynaptic dopaminergic system in Tourette syndrome. Adv Neurol 1992;58:227–31.Google Scholar

Singer, HS, Wong, DF, Brown, JE, Brandt, J, Krafft, L, Shaya, E, Dannals, RF, Wagner, HN Jr. Positron emission tomography evaluation of dopamine D-2 receptors in adults with Tourette syndrome. Adv Neurol 1992;58:233–9.Google Scholar

Erenberg, G. Treatment of Tourette syndrome with neuroleptic drugs. Adv Neurol 1992;58:241–3.Google Scholar

Goetz, CG. Clonidine and clonazepam in Tourette syndrome. Adv Neurol 1992;58:245–51.Google Scholar

Chappell, PB, Leckman, JF, Riddle, MA, Anderson, GM, Listwack, SJ, Ort, SI, Hardin, MT, Scahill, LD, Cohen, DJ. Neuroendocrine and behavioral effects of naloxone in Tourette syndrome. Adv Neurol 1992;58:253–62.Google Scholar

LeWitt, PA. Therapeutics of Tourette syndrome: New medication approaches. Adv Neurol 1992;58:263–70.Google Scholar

Sverd, J, Gadow, KD, Nolan, EE, Sprafkin, J, Ezor, SN. Methylphenidate in hyperactive boys with comorbid tic disorder. I. Clinic evaluations. Adv Neurol 1992;58:271–81.Google Scholar

King, RA, Riddle, MA, Goodman, WK. Psychopharmacology of obsessive-compulsive disorder in Tourette syndrome. Adv Neurol 1992;58:283–91.Google Scholar

Wurtman, RJ. Effects of foods on the brain: Possible implications for understanding and treating Tourette syndrome. Adv Neurol 1992;58:293–301.Google Scholar

Haslam, RH. Is there a role for megavitamin therapy in the treatment of attention deficit hyperactivity disorder? Adv Neurol 1992;58:303–10.Google Scholar

Burd, L, Kerbeshian, J. Educational management of children with Tourette syndrome. Adv Neurol 1992;58:311–17.Google Scholar

Harper, G. The family in Tourette syndrome. Adv Neurol 1992;58:319–22.Google Scholar

Nomura, Y, Kita, M, Segawa, M. Social adaptation of Tourette syndrome families in Japan. Adv Neurol 1992;58:323–32.Google Scholar

Baer, L. Behavior therapy for obsessive-compulsive disorder and trichotillomania: Implications for Tourette syndrome. Adv Neurol 1992;58:333–40.Google Scholar

Cohen, DJ, Friedhoff, AJ, Leckman, JF, Chase, TN. Tourette syndrome: Extending basic research to clinical care. Adv Neurol 1992;58:341–62.Google Scholar

Jankovic, J. Preface. Neurol Clin 1997;15:xv–xvi.Google Scholar

Kompoliti, K, Goetz, CG. Clinical rating and quantitative assessment of tics. Neurol Clin 1997;15:239–54.Google Scholar

Como, PG. Neuropsychological tests for obsessive-compulsive disorder and attention deficit hyperactivity disorder. Neurol Clin 1997;15:255–65.Google Scholar

Jankovic, J. Phenomenology and classification of tics. Neurol Clin 1997;15:267–75.Google Scholar

Coffey, BJ, Park, KS. Behavioral and emotional aspects of Tourette syndrome. Neurol Clin 1997;15:277–89.Google Scholar

Bruun, RD, Budman, CL. The course and prognosis of Tourette syndrome. Neurol Clin 1997;15:291–8.Google Scholar

Singer, C. Coprolalia and other coprophenomena. Neurol Clin 1997;15:299–308.Google Scholar

Kumar, R, Lang, AE. Secondary tic disorders. Neurol Clin 1997;15:309–31.Google Scholar

Hallett, JJ, Kiessling, SL. Neuroimmunology of tics and other childhood hyperkinesias. Neurol Clin 1997;15:333–44.Google Scholar

Stern, JS, Robertson, MM. Tics associated with autistic and pervasive developmental disorders. Neurol Clin 1997;15:345–55.Google Scholar

Singer, HS. Neurobiology of Tourette syndrome. Neurol Clin 1997;15:357–79.Google Scholar

Alsobrook, JP, Pauls, DL. The genetics of Tourette syndrome. Neurol Clin 1997;15:381–93.Google Scholar

Tanner, CM, Goldman, SM. Epidemiology of Tourette syndrome. Neurol Clin 1997;15:395–402.Google Scholar

Kurlan, R. Treatment of tics. Neurol Clin 1997;15:403–9.Google Scholar

Freeman, RD. Attention deficit hyperactivity disorder in the presence of Tourette syndrome. Neurol Clin 1997;15:411–20.Google Scholar

Rapoport, JL, Inoff-Germain, G. Medical and surgical treatment of obsessive-compulsive disorder. Neurol Clin 1997;15:421–8.Google Scholar

Chappell, PB, Scahill, LD, Leckman, JF. Future therapies of Tourette syndrome. Neurol Clin 1997;15:429–50.Google Scholar

Kurlan, R. Future direction of research in Tourette syndrome. Neurol Clin 1997;15:451–6.Google Scholar

Packer, LE. Social and educational resources for patients with Tourette syndrome. Neurol Clin 1997;15:457–73.Google Scholar

Hollander, E. Clinical aspects of Tourette syndrome. CNS Spectrums 1999;4(2):15–20.Google Scholar

Erenberg, G. Toward understanding Tourette syndrome. CNS Spectrums 1999;4(2):21.Google Scholar

Hollenbeck, P. How life imitates Tourette syndrome: Reflections of an afflicted neuroscientist. CNS Spectrums 1999;4(2):22–3.Google Scholar

Kushner, HI. From Gilles de la Tourette’s disease to Tourette syndrome: A history. CNS Spectrums 1999;4(2):24–35.Google Scholar

Erenberg, G. The clinical neurology of Tourette syndrome. CNS Spectrums 1999;4(2):36–53.Google Scholar

Walkup, JT. The psychiatry of Tourette syndrome. CNS Spectrums 1999;4(2):54–61.Google Scholar

Kurlan, R. Investigating Tourette syndrome as a neurologic sequela of rheumatic fever. CNS Spectrums 1999;4(2):62–7.Google Scholar

Silver, AA, Douglas Shytle, R, Sanberg, PR. Clinical experience with transdermal nicotine patch in Tourette syndrome. CNS Spectrums 1999;4(2):68–76.Google Scholar

Guarda, AS, Treasure, J, Robertson, MM. Eating disorders and Tourette syndrome: A case series of comorbidity and associated obsessive-compulsive symptomatology. CNS Spectrums 1999;4(2):77–80.Google Scholar

Hollander, E. The neuroscience of the Tourette syndrome spectrum. CNS Spectrums 1999;4(3):13–15.Google Scholar

Swerdlow, NR. Tourette syndrome: Lessons from a model. CNS Spectrums 1999;4(3):16–17.Google Scholar

Fuerst, ML. An interview with Jim Eisenreich. CNS Spectrums 1999;4(3):18–20.Google Scholar

Swerdlow, NR, Zinner, S, Farber, RH, Seacrist, C, Hartston, H. Symptoms in obsessive-compulsive disorder and Tourette syndrome: A spectrum? CNS Spectrums 1999;4(3):21–33.Google Scholar

Alsobrook, JP. The genetics of Tourette syndrome. CNS Spectrums 1999;4(3):34–53.Google Scholar

Wright, CI, Peterson, BS, Rauch, SL. Neuroimaging studies in Tourette syndrome. CNS Spectrums 1999;4(3):54–61.Google Scholar

Swerdlow, NR, Young, AB. Neuropathology in Tourette syndrome. CNS Spectrums 1999;4(3):65–74.Google Scholar

Leckman, JF, Peterson, BS, King, RA, Scahill, L, Cohen, DJ. Phenomenology of tics and natural history of tic disorders. Adv Neurol 2001;85:1–14.Google Scholar

Jankovic, J. Differential diagnosis and etiology of tics. Adv Neurol 2001;85:15–29.Google Scholar

Goetz, CG, Kompoliti, K. Rating scales and quantitative assessment of tics. Adv Neurol 2001;85:31–42.Google Scholar

Miguel, EC, do Rosário-Campos, MC, Shavitt, RG, Hounie, AG, Mercadante, MT. The tic-related obsessive-compulsive disorder phenotype and treatment implications. Adv Neurol 2001;85:43–55.Google Scholar

Spencer, T, Biederman, J, Coffey, B, Geller, D, Faraone, S, Wilens, T. Tourette disorder and ADHD. Adv Neurol 2001;85:57–77.Google Scholar

King, RA, Scahill, L. Emotional and behavioral difficulties associated with Tourette syndrome. Adv Neurol 2001;85:79–88.Google Scholar

Rapin, I. Autism spectrum disorders: Relevance to Tourette syndrome. Adv Neurol 2001;85:89–101.Google Scholar

Como, PG. Neuropsychological function in Tourette syndrome. Adv Neurol 2001;85:103–11.Google Scholar

Mink, JW. Neurobiology of basal ganglia circuits in Tourette syndrome: Faulty inhibition of unwanted motor patterns? Adv Neurol 2001;85:113–22.Google Scholar

Graybiel, AM, Canales, JJ. The neurobiology of repetitive behaviors: Clues to the neurobiology of Tourette syndrome. Adv Neurol 2001;85:123–31.Google Scholar

Walters, JR, Ruskin, DN, Baek, D, Allers, KA, Bergstrom, DA. Cognitive function paradigms: Implications of neurophysiological studies of dopamine stimulants for Tourette syndrome and comorbid attention-deficit hyperactivity disorder. Adv Neurol 2001;85:133–49.Google Scholar

Swerdlow, NR, Young, AB. Neuropathology in Tourette syndrome: An update. Adv Neurol 2001;85:151–61.Google Scholar

Singer, HS, Wendlandt, JT. Neurochemistry and synaptic neurotransmission in Tourette syndrome. Adv Neurol 2001;85:163–78.Google Scholar

Peterson, BS. Neuroimaging studies of Tourette syndrome: A decade of progress. Adv Neurol 2001;85:179–96.Google Scholar

Castellanos, FX. Neural substrates of attention-deficit hyperactivity disorder. Adv Neurol 2001;85:197–206.Google Scholar

Rauch, SL, Whalen, PJ, Curran, T, Shin, LM, Coffey, BJ, Savage, CR, McInerney, SC, Baer, L, Jenike, MA. Probing striato-thalamic function in obsessive-compulsive disorder and Tourette syndrome using neuroimaging methods. Adv Neurol 2001;85:207–24.Google Scholar

George, MS, Sallee, FR, Nahas, Z, Oliver, NC, Wassermann, EM. Transcranial magnetic stimulation (TMS) as a research tool in Tourette syndrome and related disorders. Adv Neurol 2001;85:225–35.Google Scholar

Hallett, M. Neurophysiology of tics. Adv Neurol 2001;85:237–44.Google Scholar

Rothenberger, A, Kostanecka, T, Kinkelbur, J, Cohrs, S, Woerner, W, Hajak, G. Sleep and Tourette syndrome. Adv Neurol 2001;85:245–59.Google Scholar

Scahill, L, Tanner, C, Dure, L. The epidemiology of tics and Tourette syndrome in children and adolescents. Adv Neurol 2001;85:261–71.Google Scholar

Walkup, JT. Epigenetic and environmental risk factors in Tourette syndrome. Adv Neurol 2001;85:273–9.Google Scholar

Pauls, DL, Tourette Syndrome Association International Consortium on Genetics. Update on the genetics of Tourette syndrome. Adv Neurol 2001;85:281–93.Google Scholar

Bessen, DE, Lombroso, PJ. Group A streptococcal infections and their potential role in neuropsychiatric disease. Adv Neurol 2001;85:295–305.Google Scholar

Kurlan, R. Could Tourette syndrome be a neurologic manifestation of rheumatic fever? Adv Neurol 2001;85:307–10.Google Scholar

Hamilton, CS, Garvey, MA, Swedo, SE. Therapeutic implications of immunology for tics and obsessive-compulsive disorder. Adv Neurol 2001;85:311–18.Google Scholar

Piacentini, J, Chang, S. Behavioral treatments for Tourette syndrome and tic disorders: State of the art. Adv Neurol 2001;85:319–31.Google Scholar

Arnsten, AF. Modulation of prefrontal cortical-striatal circuits: Relevance to therapeutic treatments for Tourette syndrome and attention-deficit hyperactivity disorder. Adv Neurol 2001;85:333–41.Google Scholar

Riddle, MA, Carlson, J. Clinical psychopharmacology for Tourette syndrome and associated disorders. Adv Neurol 2001;85:343–54.Google Scholar

Lang, AE. Update on the treatment of tics. Adv Neurol 2001;85:355–62.Google Scholar

Hollenbeck, PJ. Insight and hindsight into Tourette syndrome. Adv Neurol 2001;85:363–7.Google Scholar

Leckman, JF, Cohen, DJ, Goetz, CG, Jankovic, J. Tourette syndrome: Pieces of the puzzle. Adv Neurol 2001;85:369–90.Google Scholar

Segawa, M, Nomura, Y. Preface. Brain Develop 2003;25(Suppl. 1):S1–2.Google Scholar

Groenewegen, HJ, van den Heuvel, OA, Cath, DC, Voorn, P, Veltman, DJ. Does an imbalance between the dorsal and ventral striatopallidal systems play a role in Tourette’s syndrome? A neuronal circuit approach. Brain Develop 2003;25(Suppl. 1):S3–14.Google Scholar

Saka, E, Graybiel, AM. Pathophysiology of Tourette’s syndrome: Striatal pathways revisited. Brain Develop 2003;25(Suppl. 1):S15–19.Google Scholar

Kimura, M, Yamada, H, Matsumoto, N. Tonically active neurons in the striatum encode motivational contexts of action. Brain Develop 2003;25(Suppl. 1):S20–3.Google Scholar

Leckman, JF. Phenomenology of tics and natural history of tic disorders. Brain Develop 2003;25(Suppl. 1):S24–8.Google Scholar

Wang, H-S, Kuo, M-F. Tourette’s syndrome in Taiwan: An epidemiological study of tic disorders in an elementary school at Taipei County. Brain Develop 2003;25(Suppl. 1):S29–31.Google Scholar

Ohta, M, Kano, Y. Clinical characteristics of adult patients with tics and/or Tourette’s syndrome. Brain Develop 2003;25(Suppl. 1):S32–6.Google Scholar

Nomura, Y, Segawa, M. Neurology of Tourette’s syndrome (TS) – TS as a developmental dopamine disorder: A hypothesis. Brain Develop 2003;25(Suppl. 1):S37–42.Google Scholar

Wang, H-S, Kuo, M-F. Sonographic lenticulostriate vasculopathy in infancy with tic and other neuropsychiatric disorders developed after 7 to 9 years of follow-up. Brain Develop 2003;25(Suppl. 1):S43–7.Google Scholar

Nomura, Y, Fukuda, H, Terao, Y, Hikosaka, O, Segawa, M. Abnormalities of voluntary saccades in Gilles de la Tourette’s syndrome: Pathophysiological consideration. Brain Develop 2003;25(Suppl. 1):S48–54.Google Scholar

Grados, MA, Walkup, J, Walford, S. Genetics of obsessive-compulsive disorders: New findings and challenges. Brain Develop 2003;25(Suppl. 1):S55–61.Google Scholar

Segawa, M. Neurophysiology of Tourette’s syndrome: Pathophysiological considerations. Brain Develop 2003;25(Suppl. 1):S62–9.Google Scholar

Singer, HS, Minzer, K. Neurobiology of Tourette’s syndrome: Concepts of neuroanatomic localization and neurochemical abnormalities. Brain Develop 2003;25(Suppl. 1):S70–84.Google Scholar

Sandor, P. From the editor. J Psychosom Res 2003;55(1):1–2.Google Scholar

Robertson, MM. Diagnosing Tourette syndrome: Is it a common disorder? J Psychosom Res 2003;55(1):3–6.Google Scholar

Pauls, DL. An update on the genetics of Gilles de la Tourette syndrome. J Psychosom Res 2003;55(1):7–12.Google Scholar

Gerard, E, Peterson, BS. Developmental processes and brain imaging studies in Tourette syndrome. J Psychosom Res 2003;55(1):13–22.Google Scholar

Kostanecka-Endress, T, Banaschewski, T, Kinkelbur, J, Wüllner, I, Lichtblau, S, Cohrs, S, Rüther, E, Woerner, W, Hajak, G, Rothenberger, A. Disturbed sleep in children with Tourette syndrome: A polysomnographic study. J Psychosom Res 2003;55(1):23–9.Google Scholar

Singer, HS, Loiselle, C. PANDAS: A commentary. J Psychosom Res 2003;55(1):31–9.Google Scholar

Sandor, P. Pharmacological management of tics in patients with TS. J Psychosom Res 2003;55(1):41–8.Google Scholar

Miguel, EC, Shavitt, RG, Ferrão, YA, Brotto, SA, Diniz, JB. How to treat OCD in patients with Tourette syndrome. J Psychosom Res 2003;55(1):49–57.Google Scholar

Budman, CL, Rockmore, L, Stokes, J, Sossin, M. Clinical phenomenology of episodic rage in children with Tourette syndrome. J Psychosom Res 2003;55(1):59–65.Google Scholar

Greene, RW, Ablon, JS, Goring, JC. A transactional model of oppositional behavior: Underpinnings of the collaborative problem solving approach. J Psychosom Res 2003;55(1):67–75.Google Scholar

Woods, DW. Introduction to the special issue on the Clinical Management of Tourette’s Syndrome: A behavioral perspective. Behav Modification 2005;29(5–6):711–15.Google Scholar

Meidinger, AL, Miltenberger, RG, Himle, M, Omvig, M, Trainor, C, Crosby, R. An investigation of tic suppression and the rebound effect in Tourette’s disorder. Behav Modification 2005;29(5–6):716–45.Google Scholar

Osmon, DC, Smerz, JM. Neuropsychological evaluation in the diagnosis and treatment of Tourette’s syndrome. Behav Modification 2005;29(5–6):746–83.Google Scholar

Mansueto, CS, Keuler, DJ. Tic or compulsion? It’s Tourettic OCD. Behav Modification 2005;29(5–6):784–99.Google Scholar

Piacentini, J, Chang, S. Habit reversal training for tic disorders in children and adolescents. Behav Modification 2005;29(5–6):803–22.Google Scholar

Gilman, R, Connor, N, Haney, M. A school-based application of modified habit reversal for Tourette syndrome via a translator: A case study. Behav Modification 2005;29(5–6):823–38.Google Scholar

Watson, TS, Dufrene, B, Weaver, A, Butler, T, Meeks, C. Brief antecedent assessment and treatment of tics in the general education classroom: A preliminary investigation. Behav Modification 2005;29(5–6):839–57.Google Scholar

Carr, JE, Chong, IM. Habit reversal treatment of tic disorders: A methodological critique of the literature. Behav Modification 2005;29(5–6):858–75.Google Scholar

Packer, LE. Tic-related school problems: Impact on functioning, accommodations, and interventions. Behav Modification 2005;29(5–6):876–99.Google Scholar

Woods, DW, Marcks, BA. Controlled evaluation of an educational intervention used to modify peer attitudes and behavior toward persons with Tourette’s syndrome. Behav Modification 2005;29(5–6):900–12.Google Scholar

Leckman, JF, Bloch, MH, King, RA, Scahill, L. Phenomenology of tics and natural history of tic disorders. Adv Neurol 2006;99:1–16.Google Scholar

Denckla, MB. Attention deficit hyperactivity disorder: The childhood co-morbidity that most influences the disability burden in Tourette syndrome. Adv Neurol 2006;99:17–21.Google Scholar

Hounie, AG, do Rosario-Campos, MC, Diniz, JB, Shavitt, RG, Ferrão, YA, Lopes, AC, Mercadante, MT, Busatto, GF, Miguel, EC. Obsessive-compulsive disorder in Tourette syndrome. Adv Neurol 2006;99:22–38.Google Scholar

Robertson, MM, Orth, M. Behavioral and affective disorders in Tourette syndrome. Adv Neurol 2006;99:39–60.Google Scholar

Jankovic, J, Mejia, NI. Tics associated with other disorders. Adv Neurol 2006;99:61–8.Google Scholar

Swerdlow, NR, Sutherland, AN. Preclinical models relevant to Tourette syndrome. Adv Neurol 2006;99:69–88.Google Scholar

Mink, JW. Neurobiology of basal ganglia and Tourette syndrome: Basal ganglia circuits and thalamocortical outputs. Adv Neurol 2006;99:89–98.Google Scholar

Albin, RL. Neurobiology of basal ganglia and Tourette syndrome: Striatal and dopamine function. Adv Neurol 2006;99:99–106.Google Scholar

Gilbert, DL. Motor cortex inhibitory function in Tourette syndrome, attention deficit disorder, and obsessive compulsive disorder: Studies using transcranial magnetic stimulation. Adv Neurol 2006;99:107–14.Google Scholar

Butler, T, Stern, E, Silbersweig, D. Functional neuroimaging of Tourette syndrome: Advances and future directions. Adv Neurol 2006;99:115–29.Google Scholar

Pauls, DL. A genome-wide scan and fine mapping in Tourette syndrome families. Adv Neurol 2006;99:130–5.Google Scholar

McMahon, WM, Illmann, CL, McGinn, MM. Web-based consensus diagnosis for genetics studies of Gilles de la Tourette syndrome. Adv Neurol 2006;99:136–43.Google Scholar

King, NM. Genes and Tourette syndrome: Scientific, ethical, and social implications. Adv Neurol 2006;99:144–7.Google Scholar

Murphy, TK, Husted, DS, Edge, PJ. Preclinical/clinical evidence of central nervous system infectious etiology in PANDAS. Adv Neurol 2006;99:148–58.Google Scholar

Giovannoni, G. PANDAS: Overview of the hypothesis. Adv Neurol 2006;99:159–65.Google Scholar

Singer, HS, Williams, PN. Autoimmunity and pediatric movement disorders. Adv Neurol 2006;99:166–78.Google Scholar

King, RA. PANDAS: To treat or not to treat? Adv Neurol 2006;99:179–83.Google Scholar

Scahill, L, Williams, S, Schwab-Stone, M, Applegate, J, Leckman, JF. Disruptive behavior problems in a community sample of children with tic disorders. Adv Neurol 2006;99:184–90.Google Scholar

Dure, LS 4th, DeWolfe, J. Treatment of tics. Adv Neurol 2006;99:191–6.Google Scholar

Gadow, KD, Sverd, J. Attention deficit hyperactivity disorder, chronic tic disorder, and methylphenidate. Adv Neurol 2006;99:197–207.Google Scholar

Coffey, BJ, Shechter, RL. Treatment of co-morbid obsessive compulsive disorder, mood, and anxiety disorders. Adv Neurol 2006;99:208–21.Google Scholar

Budman, CL. Treatment of aggression in Tourette syndrome. Adv Neurol 2006;99:222–6.Google Scholar

Piacentini, JC, Chang, SW. Behavioral treatments for tic suppression: Habit reversal training. Adv Neurol 2006;99:227–33.Google Scholar

Woods, DW, Himle, MB, Conelea, CA. Behavior therapy: Other interventions for tic disorders. Adv Neurol 2006;99:234–40.Google Scholar

Malone, DA Jr, Pandya, MM. Behavioral neurosurgery. Adv Neurol 2006;99:241–7.Google Scholar

Kurlan, R. Future and alternative therapies in Tourette syndrome. Adv Neurol 2006;99:248–53.Google Scholar

Maria, BL. Neurobiology of disease in children: Tourette syndrome. J Child Neurol 2006;21(8):627–8.Google Scholar

Mink, JW, Hollenbeck, PJ, Swerdlow, NR, Levi-Pearl, S. Tourette syndrome research. J Child Neurol 2006;21(8):629.Google Scholar

Olson, LL, Singer, HS, Goodman, WK, Maria, BL. Tourette syndrome: Diagnosis, strategies, therapies, pathogenesis, and future research directions. J Child Neurol 2006;21(8):630–41.Google Scholar

Leckman, JF, Bloch, MH, Scahill, L, King, RA. Tourette syndrome: The self under siege. J Child Neurol 2006;21(8):642–9.Google Scholar

Scahill, L, Sukhodolsky, DG, Bearss, K, Findley, D, Hamrin, V, Carroll, DH, Rains, AL. Randomized trial of parent management training in children with tic disorders and disruptive behavior. J Child Neurol 2006;21(8):650–6.Google Scholar

Gaze, C, Kepley, HO, Walkup, JT. Co-occurring psychiatric disorders in children and adolescents with Tourette syndrome. J Child Neurol 2006;21(8):657–64.Google Scholar

Keen-Kim, D, Freimer, NB. Genetics and epidemiology of Tourette syndrome. J Child Neurol 2006;21(8):665–71.Google Scholar

Frey, KA, Albin, RL. Neuroimaging of Tourette syndrome. J Child Neurol 2006;21(8):672–7.Google Scholar

Harris, K, Singer, HS. Tic disorders: Neural circuits, neurochemistry, and neuroimmunology. J Child Neurol 2006;21(8):678–89.Google Scholar

Gilbert, D. Treatment of children and adolescents with tics and Tourette syndrome. J Child Neurol 2006;21(8):690–700.Google Scholar

Denckla, MB. Attention-deficit hyperactivity disorder (ADHD) comorbidity: A case for “pure” Tourette syndrome? J Child Neurol 2006;21(8):701–3.Google Scholar

Goodman, WK, Storch, EA, Geffken, GR, Murphy, TK. Obsessive-compulsive disorder in Tourette syndrome. J Child Neurol 2006;21(8):704–14.Google Scholar

Neimat, JS, Patil, PG, Lozano, AM. Novel surgical therapies for Tourette syndrome. J Child Neurol 2006;21(8):715–18.Google Scholar

Himle, MB, Woods, DW, Piacentini, JC, Walkup, JT. Brief review of habit reversal training for Tourette syndrome. J Child Neurol 2006;21(8):719–25.Google Scholar

Rothenberger, A, Roessner, V, Banaschewski, T, Leckman, JF. Co-existence of tic disorders and attention-deficit/hyperactivity disorder – recent advances in understanding and treatment. Eur Child Adolesc Psychiatr 2007;16(Suppl. 1):S1–4.Google Scholar

Banaschewski, T, Neale, BM, Rothenberger, A, Roessner, V. Comorbidity of tic disorders and ADHD: Conceptual and methodological considerations. Eur Child Adolesc Psychiatr 2007;16(Suppl. 1):S5–14.Google Scholar

Freeman, RD, Tourette Syndrome International Database Consortium. Tic disorders and ADHD: Answers from a world-wide clinical dataset on Tourette syndrome. Eur Child Adolesc Psychiatr 2007;16(Suppl. 1):S15–23.Google Scholar

Roessner, V, Becker, A, Banaschewski, T, Freeman, RD, Rothenberger, A, Tourette Syndrome International Database Consortium. Developmental psychopathology of children and adolescents with Tourette syndrome: Impact of ADHD. Eur Child Adolesc Psychiatr 2007;16(Suppl. 1):S24–35.Google Scholar

Roessner, V, Becker, A, Banaschewski, T, Rothenberger, A. Executive functions in children with chronic tic disorders with/without ADHD: New insights. Eur Child Adolesc Psychiatr 2007;16(Suppl. 1):S36–44.Google Scholar

Kirov, R, Banaschewski, T, Uebel, H, Kinkelbur, J, Rothenberger, A. REM-sleep alterations in children with co-existence of tic disorders and attention-deficit/hyperactivity disorder: Impact of hypermotor symptoms. Eur Child Adolesc Psychiatr 2007;16(Suppl. 1):S45–50.Google Scholar

Sukhodolsky, DG, Leckman, JF, Rothenberger, A, Scahill, L. The role of abnormal neural oscillations in the pathophysiology of co-occurring Tourette syndrome and attention-deficit/hyperactivity disorder. Eur Child Adolesc Psychiatr 2007;16(Suppl. 1):S51–9.Google Scholar

Plessen, KJ, Royal, JM, Peterson, BS. Neuroimaging of tic disorders with co-existing attention-deficit/hyperactivity disorder. Eur Child Adolesc Psychiatr 2007;16(Suppl. 1):S60–70.Google Scholar

Hoekstra, PJ, Anderson, GM, Troost, PW, Kallenberg, CG, Minderaa, RB. Plasma kynurenine and related measures in tic disorder patients. Eur Child Adolesc Psychiatr 2007;16(Suppl. 1):S71–7.Google Scholar

Poncin, Y, Sukhodolsky, DG, McGuire, J, Scahill, L. Drug and non-drug treatments of children with ADHD and tic disorders. Eur Child Adolesc Psychiatr 2007;16(Suppl. 1):S78–88.Google Scholar

Döpfner, M, Rothenberger, A. Behavior therapy in tic-disorders with co-existing ADHD. Eur Child Adolesc Psychiatr 2007;16(Suppl. 1):S89–99.Google Scholar

Robertson, MM, Cavanna, AE. The many faces of Gilles de la Tourette syndrome. J Psychosom Res 2009;67(6):467–8.Google Scholar

Rickards, H, Cavanna, AE. Gilles de la Tourette: The man behind the syndrome. J Psychosom Res 2009;67(6):469–74.Google Scholar

Robertson, MM, Eapen, V, Cavanna, AE. The international prevalence, epidemiology and clinical phenomenology of Tourette syndrome: A cross-cultural perspective. J Psychosom Res 2009;67(6):475–83.Google Scholar

Monaco, F, Servo, S, Cavanna, AE. Famous people with Gilles de la Tourette syndrome? J Psychosom Res 2009;67(6):485–90.Google Scholar

Grados, MA, Mathews, CA. Clinical phenomenology and phenotype variability in Tourette syndrome. J Psychosom Res 2009;67(6):491–6.Google Scholar

Bloch, MH, Leckman, JF. Clinical course of Tourette syndrome. J Psychosom Res 2009;67(6):497–501.Google Scholar

Eddy, CM, Rizzo, R, Cavanna, AE. Neuropsychological aspects of Tourette syndrome: A review. J Psychosom Res 2009;67(6):503–13.Google Scholar

Kerbeshian, J, Peng, CZ, Burd, L. Tourette syndrome and comorbid early-onset schizophrenia. J Psychosom Res 2009;67(6):515–23.Google Scholar

Eapen, V, Crncec, R. Tourette syndrome in children and adolescents: Special considerations. J Psychosom Res 2009;67(6):525–32.Google Scholar

O’Rourke, JA, Scharf, JM, Yu, D, Pauls, DL. The genetics of Tourette syndrome: A review. J Psychosom Res 2009;67(6):533–45.Google Scholar

Martino, D, Defazio, G, Giovannoni, G. The PANDAS subgroup of tic disorders and childhood-onset obsessive-compulsive disorder. J Psychosom Res 2009;67(6):547–57.Google Scholar

Plessen, KJ, Bansal, R, Peterson, BS. Imaging evidence for anatomical disturbances and neuroplastic compensation in persons with Tourette syndrome. J Psychosom Res 2009;67(6):559–73.Google Scholar

Rickards, H. Functional neuroimaging in Tourette syndrome. J Psychosom Res 2009;67(6):575–84.Google Scholar

Porta, M, Sassi, M, Ali, F, Cavanna, AE, Servello, D. Neurosurgical treatment for Gilles de la Tourette syndrome: The Italian perspective. J Psychosom Res 2009;67(6):585–90.Google Scholar

Orth, M. Transcranial magnetic stimulation in Gilles de la Tourette syndrome. J Psychosom Res 2009;67(6):591–8.Google Scholar

Nagai, Y, Cavanna, AE, Critchley, HD. Influence of sympathetic arousal on tics: Implications for a therapeutic behavioral intervention for Tourette syndrome. J Psychosom Res 2009;67(6):599–605.Google Scholar

Coffey, BJ, Rapoport, J. Obsessive-compulsive disorder and Tourette’s disorder: Where are we now? J Child Adolesc Psychopharmacol 2010;20(4):235–6.Google Scholar

Leckman, JF, Bloch, MH, Smith, ME, Larabi, D, Hampson, M. Neurobiological substrates of Tourette’s disorder. J Child Adolesc Psychopharmacol 2010;20(4):237–47.Google Scholar

Párraga, HC, Harris, KM, Párraga, KL, Balen, GM, Cruz, C. An overview of the treatment of Tourette’s disorder and tics. J Child Adolesc Psychopharmacol 2010;20(4):249–62.Google Scholar

Wu, SW, Harris, E, Gilbert, DL. Tic suppression: The medical model. J Child Adolesc Psychopharmacol 2010;20(4):263–76.Google Scholar

Kompoliti, K, Stebbins, GT, Goetz, CG, Fan, W. Association between antipsychotics and body mass index when treating patients with tics. J Child Adolesc Psychopharmacol 2010;20(4):277–81.Google Scholar

Lyon, GJ, Samar, SM, Conelea, C, Trujillo, MR, Lipinski, CM, Bauer, CC, Brandt, BC, Kemp, JJ, Lawrence, ZE, Howard, J, Castellanos, FX, Woods, D, Coffey, BJ. Testing tic suppression: Comparing the effects of dexmethylphenidate to no medication in children and adolescents with attention-deficit/hyperactivity disorder and Tourette’s disorder. J Child Adolesc Psychopharmacol 2010;20(4):283–9.Google Scholar

Cui, YH, Zheng, Y, Yang, YP, Liu, J, Li, J. Effectiveness and tolerability of aripiprazole in children and adolescents with Tourette’s disorder: A pilot study in China. J Child Adolesc Psychopharmacol 2010;20(4):291–8.Google Scholar

Mancuso, E, Faro, A, Joshi, G, Geller, DA. Treatment of pediatric obsessive-compulsive disorder: A review. J Child Adolesc Psychopharmacol 2010;20(4):299–308.Google Scholar

Grant, P, Song, JY, Swedo, SE. Review of the use of the glutamate antagonist riluzole in psychiatric disorders and a description of recent use in childhood obsessive-compulsive disorder. J Child Adolesc Psychopharmacol 2010;20(4):309–15.Google Scholar

Murphy, TK, Kurlan, R, Leckman, J. The immunobiology of Tourette’s disorder, pediatric autoimmune neuropsychiatric disorders associated with Streptococcus, and related disorders: A way forward. J Child Adolesc Psychopharmacol 2010;20(4):317–31.Google Scholar

Bernstein, GA, Victor, AM, Pipal, AJ, Williams, KA. Comparison of clinical characteristics of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and childhood obsessive-compulsive disorder. J Child Adolesc Psychopharmacol 2010;20(4):333–40.Google Scholar

Cavanna, AE. Researching Tourette syndrome in Europe. Behav Neurol 2013;27(1):1–2.Google Scholar

Rickards, H, Paschou, P, Rizzo, R, Stern, JS. A brief history of the European Society for the Study of Tourette Syndrome. Behav Neurol 2013;27(1):3–5.Google Scholar

Mol Debes, NM. Co-morbid disorders in Tourette syndrome. Behav Neurol 2013;27(1):7–14.Google Scholar

Eddy, CM, Cavanna, AE. Altered social cognition in Tourette syndrome: Nature and implications. Behav Neurol 2013;27(1):15–22.Google Scholar

Elamin, I, Edwards, MJ, Martino, D. Immune dysfunction in Tourette syndrome. Behav Neurol 2013;27(1):23–32.Google Scholar

Eichele, H, Plessen, KJ. Neural plasticity in functional and anatomical MRI studies of children with Tourette syndrome. Behav Neurol 2013;27(1):33–45.Google Scholar

Rothenberger, A, Roessner, V. Functional neuroimaging investigations of motor networks in Tourette syndrome. Behav Neurol 2013;27(1):47–55.Google Scholar

Orth, M, Münchau, A. Transcranial magnetic stimulation studies of sensorimotor networks in Tourette syndrome. Behav Neurol 2013;27(1):57–64.Google Scholar

Rajagopal, S, Seri, S, Cavanna, AE. Premonitory urges and sensorimotor processing in Tourette syndrome. Behav Neurol 2013;27(1):65–73.Google Scholar

Beetsma, DJ, van den Hout, MA, Engelhard, IM, Rijkeboer, MM, Cath, DC. Does repeated ticking maintain tic behavior? An experimental study of eye blinking in healthy individuals. Behav Neurol 2013;27(1):75–82.Google Scholar

Cavanna, AE, David, K, Bandera, V, Termine, C, Balottin, U, Schrag, A, Selai, C. Health-related quality of life in Gilles de la Tourette syndrome: A decade of research. Behav Neurol 2013;27(1):83–93.Google Scholar

Cavanna, AE, Luoni, C, Selvini, C, Blangiardo, R, Eddy, CM, Silvestri, P, Calì, P, Seri, S, Balottin, U, Cardona, F, Rizzo, R, Termine, C. The Gilles de la Tourette Syndrome-Quality of Life Scale for Children and Adolescents (GTS-QOL-C&A): Development and validation of the Italian version. Behav Neurol 2013;27(1):95–103.Google Scholar

Frank, M, Cavanna, AE. Behavioural treatments for Tourette syndrome: An evidence-based review. Behav Neurol 2013;27(1):105–17.Google Scholar

Müller-Vahl, KR. Treatment of Tourette syndrome with cannabinoids. Behav Neurol 2013;27(1):119–24.Google Scholar

Porta, M, Cavanna, AE, Zekaj, E, D’Adda, F, Servello, D. Selection of patients with Tourette syndrome for Deep Brain Stimulation (DBS) surgery. Behav Neurol 2013;27(1):125–31.Google Scholar

Ackermans, L, Neuner, I, Temel, Y, Duits, A, Kuhn, J, Visser-Vandewalle, V. Thalamic deep brain stimulation for Tourette syndrome. Behav Neurol 2013;27(1):133–8.Google Scholar

Cavanna, AE, Kavanagh, C, Robertson, MM. The future of research in Tourette syndrome. Behav Neurol 2013;27(1):139–42.Google Scholar

Martino, D, Cavanna, AE. The metamorphoses of Gilles de la Tourette syndrome. Int Rev Neurobiol 2013;112:xv–xx.Google Scholar

Martino, D, Madhusudan, N, Zis, P, Cavanna, AE. An introduction to the clinical phenomenology of Tourette syndrome. Int Rev Neurobiol 2013;112:1–32.Google Scholar

Neuner, I, Schneider, F, Shah, NJ. Functional neuroanatomy of tics. Int Rev Neurobiol 2013;112:35–71.Google Scholar

Segura, B, Strafella, AP. Functional imaging of dopaminergic neurotransmission in Tourette syndrome. Int Rev Neurobiol 2013;112:73–93.Google Scholar

Udvardi, PT, Nespoli, E, Rizzo, F, Hengerer, B, Ludolph, AG. Nondopaminergic neurotransmission in the pathophysiology of Tourette syndrome. Int Rev Neurobiol 2013;112:95–130.Google Scholar

Palminteri, S, Pessiglione, M. Reinforcement learning and Tourette syndrome. Int Rev Neurobiol 2013;112:131–53.Google Scholar

Paschou, P, Fernandez, TV, Sharp, F, Heiman, GA, Hoekstra, PJ. Genetic susceptibility and neurotransmitters in Tourette syndrome. Int Rev Neurobiol 2013;112:155–77.Google Scholar

McCairn, KW, Isoda, M. Pharmacological animal models of tic disorders. Int Rev Neurobiol 2013;112:179–209.Google Scholar

Macrì, S, Onori, MP, Roessner, V, Laviola, G. Animal models recapitulating the multifactorial origin of Tourette syndrome. Int Rev Neurobiol 2013;112:211–37.Google Scholar

Martino, D, Macerollo, A, Leckman, JF. Neuroendocrine aspects of Tourette syndrome. Int Rev Neurobiol 2013;112:239–79.Google Scholar

Mogwitz, S, Buse, J, Ehrlich, S, Roessner, V. Clinical pharmacology of dopamine-modulating agents in Tourette’s syndrome. Int Rev Neurobiol 2013;112:281–349.Google Scholar

Hartmann, A. Clinical pharmacology of nondopaminergic drugs in Tourette syndrome. Int Rev Neurobiol 2013;112:351–72.Google Scholar

Cavanna, AE, Nani, A. Antiepileptic drugs and Tourette syndrome. Int Rev Neurobiol 2013;112:373–89.Google Scholar

Neri, V, Cardona, F. Clinical pharmacology of comorbid obsessive-compulsive disorder in Tourette syndrome. Int Rev Neurobiol 2013;112:391–414.Google Scholar

Rizzo, R, Gulisano, M. Clinical pharmacology of comorbid attention deficit hyperactivity disorder in Tourette syndrome. Int Rev Neurobiol 2013;112:415–44.Google Scholar

Termine, C, Selvini, C, Rossi, G, Balottin, U. Emerging treatment strategies in Tourette syndrome: What’s in the pipeline? Int Rev Neurobiol 2013;112:445–80.Google Scholar

Madruga-Garrido, M, Mir, P. Tics and other stereotyped movements as side effects of pharmacological treatment. Int Rev Neurobiol 2013;112:481–94.Google Scholar

Martino, D, Laviola, G. The multifaceted nature of Tourette syndrome: Pre-clinical, clinical and therapeutic issues. Neurosci Biobehav Rev 2013;37(6):993–6.Google Scholar

Cohen, SC, Leckman, JF, Bloch, MH. Clinical assessment of Tourette syndrome and tic disorders. Neurosci Biobehav Rev 2013;37(6):997–1007.Google Scholar

Cavanna, AE, Rickards, HE. The psychopathological spectrum of Gilles de la Tourette syndrome. Neurosci Biobehav Rev 2013;37(6):1008–15.Google Scholar

Jung, J, Jackson, SR, Parkinson, A, Jackson, GM. Cognitive control over motor output in Tourette syndrome. Neurosci Biobehav Rev 2013;37(6):1016–25.Google Scholar

Paschou, P. The genetic basis of Gilles de la Tourette syndrome. Neurosci Biobehav Rev 2013;37(6):1026–39.Google Scholar

Hoekstra, PJ, Dietrich, A, Edwards, MJ, Elamin, I, Martino, D. Environmental factors in Tourette syndrome. Neurosci Biobehav Rev 2013;37(6):1040–9.Google Scholar

Ganos, C, Roessner, V, Münchau, A. The functional anatomy of Gilles de la Tourette syndrome. Neurosci Biobehav Rev 2013;37(6):1050–62.Google Scholar

Priori, A, Giannicola, G, Rosa, M, Marceglia, S, Servello, D, Sassi, M, Porta, M. Deep brain electrophysiological recordings provide clues to the pathophysiology of Tourette syndrome. Neurosci Biobehav Rev 2013;37(6):1063–8.Google Scholar

Buse, J, Schoenefeld, K, Münchau, A, Roessner, V. Neuromodulation in Tourette syndrome: Dopamine and beyond. Neurosci Biobehav Rev 2013;37(6):1069–84.Google Scholar

Macrì, S, Proietti Onori, M, Laviola, G. Theoretical and practical considerations behind the use of laboratory animals for the study of Tourette syndrome. Neurosci Biobehav Rev 2013;37(6):1085–100.Google Scholar

Bronfeld, M, Israelashvili, M, Bar-Gad, I. Pharmacological animal models of Tourette syndrome. Neurosci Biobehav Rev 2013;37(6):1101–19.Google Scholar

Hornig, M, Lipkin, WI. Immune-mediated animal models of Tourette syndrome. Neurosci Biobehav Rev 2013;37(6):1120–38.Google Scholar

Amitai, N, Weber, M, Swerdlow, NR, Sharp, RF, Breier, MR, Halberstadt, AL, Young, JW. A novel visuospatial priming task for rats with relevance to Tourette syndrome and modulation of dopamine levels. Neurosci Biobehav Rev 2013;37(6):1139–49.Google Scholar

Hartmann, A, Worbe, Y. Pharmacological treatment of Gilles de la Tourette syndrome. Neurosci Biobehav Rev 2013;37(6):1157–61.Google Scholar

Weisman, H, Qureshi, IA, Leckman, JF, Scahill, L, Bloch, MH. Systematic review: Pharmacological treatment of tic disorders – efficacy of antipsychotic and alpha-2 adrenergic agonist agents. Neurosci Biobehav Rev 2013;37(6):1162–71.Google Scholar

van de Griendt, JM, Verdellen, CW, van Dijk, MK, Verbraak, MJ. Behavioural treatment of tics: habit reversal and exposure with response prevention. Neurosci Biobehav Rev 2013;37(6):1172–7.Google Scholar

Müller-Vahl, KR. Surgical treatment of Tourette syndrome. Neurosci Biobehav Rev 2013;37(6):1178–85.Google Scholar

Black, KJ, Jankovic, J, Hershey, T, McNaught, KS, Mink, JW, Walkup, J. Progress in research on Tourette syndrome. J Obsessive-Compulsive Related Disord 2014;3(4):359–62.Google Scholar

Eddy, CM, Cavanna, AE. Tourette syndrome and obsessive compulsive disorder: Compulsivity along the continuum. J Obsessive-Compulsive Related Disord 2014;3(4):363–71.Google Scholar

Leckman, JF, King, RA, Bloch, MH. Clinical features of Tourette syndrome and tic disorders. J Obsessive-Compulsive Related Disord 2014;3(4):372–9.Google Scholar

Pauls, DL, Fernandez, TV, Mathews, CA, State, MW, Scharf, JM. The inheritance of Tourette disorder: A review. J Obsessive-Compulsive Related Disord 2014;3(4):380–5.Google Scholar

Church, JA, Schlaggar, BL. Pediatric Tourette syndrome: Insights from recent neuroimaging studies. J Obsessive-Compulsive Related Disord 2014;3(4):386–93.Google Scholar

Scahill, L, Specht, M, Page, C. The prevalence of tic disorders and clinical characteristics in children. J Obsessive-Compulsive Related Disord 2014;3(4):394–400.Google Scholar

Visser-Vandewalle, V, Huys, D, Neuner, I, Zrinzo, L, Okun, MS, Kuhn, J. Deep brain stimulation for Tourette syndrome: The current state of the field. J Obsessive-Compulsive Related Disord 2014;3(4):401–6.Google Scholar

Gilbert, DL, Jankovic, J. Pharmacological treatment of Tourette syndrome. J Obsessive-Compulsive Related Disord 2014;3(4):407–14.Google Scholar

Capriotti, MR, Himle, MB, Woods, DW. Behavioral treatments for Tourette syndrome. J Obsessive-Compulsive Related Disord 2014;3(4):415–20.Google Scholar

Rudy, BM, Lewin, AB, Storch, EA. Introduction to the special issue: Considerations of the effects of extra-symptom variables among youth with chronic tic disorders and Tourette’s syndrome. Children’s Health Care 2015;44(3):199–204.Google Scholar

Capriotti, MR, Piacentini, JC, Himle, MB, Ricketts, EJ, Espil, FM, Lee, HJ, Turkel, JE, Woods, DW. Assessing environmental consequences of ticcing in youth with chronic tic disorders: The tic accommodation and reactions scale. Children’s Health Care 2015;44(3):205–20.Google Scholar

Eaton, CK, Gutierrez-Colina, AM, Lee, JL, Blount, RL. Predictors of experiences and attitudes at a summer camp for children and adolescents with Tourette syndrome. Children’s Health Care 2015;44(3):221–34.Google Scholar

Rozenman, M, Johnson, OE, Chang, SW, Woods, DW, Walkup, JT, Wilhelm, S, Peterson, A, Scahill, L, Piacentini, J. Relationships between premonitory urge and anxiety in youth with chronic tic disorders. Children’s Health Care 2015;44(3):235–48.Google Scholar

Ramanujam, K, Himle, MB, Hayes, LP, Woods, DW, Scahill, L, Sukhodolsky, DG, Wilhelm, S, Deckersbach, T, Peterson, AL, Specht, M, Walkup, JT, Chang, SW, Piacentini, J. Clinical correlates and predictors of caregiver strain in children with chronic tic disorders. Children’s Health Care 2015;44(3):249–63.Google Scholar

Cavanna, AE, Selvini, C, Luoni, C, Eddy, CM, Ali, F, Blangiardo, R, Gagliardi, E, Balottin, U, Termine, C. Measuring anger expression in young patients with Tourette syndrome. Children’s Health Care 2015;44(3):264–76.Google Scholar

McGuire, JF, Park, JM, Wu, MS, Lewin, AB, Murphy, TK, Storch, EA. The impact of tic severity dimensions on impairment and quality of life among youth with chronic tic disorders. Children’s Health Care 2015;44(3):277–92.Google Scholar

Nonaka, M, Matsuda, N, Kono, T, Fujio, M, Scahill, L, Kano, Y. Preliminary study of behavioral therapy for Tourette syndrome patients in Japan. Children’s Health Care 2015;44(3):293–306.Google Scholar

Budman, CL, Rosen, M, Shad, S. Fits, tantrums, and rages in TS and related disorders. Curr Develop Disord Rep 2015;2(4):273–84.Google Scholar

Hanks, CE, Lewin, AB, Mutch, PJ, Storch, EA, Murphy, TK. Social deficits and autism spectrum disorders in Tourette’s syndrome. Curr Develop Disord Rep 2015;2(4):285–92.Google Scholar

Coffey, BJ. Complexities for assessment and treatment of co-occurring ADHD and tics. Curr Develop Disord Rep 2015;2(4):293–9.Google Scholar

Greene, DJ, Schlaggar, BL, Black, KJ. Neuroimaging in Tourette syndrome: Research highlights from 2014–2015. Curr Develop Disord Rep 2015;2(4):300–8.Google Scholar

McGuire, JF, Ricketts, EJ, Piacentini, J, Murphy, TK, Storch, EA, Lewin, AB. Behavior therapy for tic disorders: An evidenced-based review and new directions for treatment research. Curr Develop Disord Rep 2015;2(4):309–17.Google Scholar

Tremblay, L, Worbe, Y, Thobois, S, Sgambato‐Faure, V, Féger, J. Selective dysfunction of basal ganglia subterritories: From movement to behavioral disorders. Mov Disord 2015;30(9):1155–70.Google Scholar

Yael, D, Vinner, E, Bar-Gad, I. Pathophysiology of tic disorders. Mov Disord 2015;30(9):1171–8.Google Scholar

Worbe, Y, Lehericy, S, Hartmann, A. Neuroimaging of tic genesis: Present status and future perspectives. Mov Disord 2015;30(9):1179–83.Google Scholar

Ganos, C, Bongert, J, Asmuss, L, Martino, D, Haggard, P, Münchau, A. The somatotopy of tic inhibition: Where and how much? Mov Disord 2015;30(9):1184–9.Google Scholar

Tinaz, S, Malone, P, Hallett, M, Horovitz, SG. Role of the right dorsal anterior insula in the urge to tic in Tourette syndrome. Mov Disord 2015;30(9):1190–7.Google Scholar

Ganos, C, Garrido, A, Navalpotro‐Gómez, I, Ricciardi, L, Martino, D, Edwards, MJ, Tsakiris, M, Haggard, P, Bhatia, KP. Premonitory urge to tic in Tourette’s is associated with interoceptive awareness. Mov Disord 2015;30(9):1198–202.Google Scholar

Bortolato, M, Di Giovanni, G. Editorial on special issue: Animal models of Tourette syndrome. J Neurosci Methods 2017;292:1.Google Scholar

Burton, FH. Back to the future: Circuit-testing TS & OCD. J Neurosci Methods 2017;292:2–11.Google Scholar

Bortolato, M, Pittenger, C. Modeling tics in rodents: Conceptual challenges and paths forward. J Neurosci Methods 2017;292:12–19.Google Scholar

Vinner, E, Israelashvili, M, Bar-Gad, I. Prolonged striatal disinhibition as a chronic animal model of tic disorders. J Neurosci Methods 2017;292:20–9.Google Scholar

Kreiss, DS, De Deurwaerdère, P. Purposeless oral activity induced by meta-chlorophenylpiperazine (m-CPP): Undefined tic-like behaviors? J Neurosci Methods 2017;292:30–6.Google Scholar

Fowler, SC, Mosher, LJ, Godar, SC, Bortolato, M. Assessment of gait and sensorimotor deficits in the D1CT-7 mouse model of Tourette syndrome. J Neurosci Methods 2017;292:37–44.Google Scholar

Roberts, K, Hemmings, AJ, McBride, SD, Parker, MO. Developing a 3-choice serial reaction time task for examining neural and cognitive function in an equine model. J Neurosci Methods 2017;292:45–52.Google Scholar

Bhakta, SG, Young, JW. The 5 choice continuous performance test (5 C-CPT): A novel tool to assess cognitive control across species. J Neurosci Methods 2017;292:53–60.Google Scholar

Grisolano, LA. Tourette’s from a neuropsychological perspective. Curr Develop Disord Rep 2018;5(2):89–94.Google Scholar

Kumar, A, Duda, L, Mainali, G, Asghar, S, Byler, D. A comprehensive review of Tourette syndrome and complementary alternative medicine. Curr Develop Disord Rep 2018;5(2):95–100.Google Scholar

Sharp, AN, Singer, HS. Standard, complementary, and future treatment options for tics. Curr Develop Disord Rep 2018;5(2):101–7.Google Scholar

Bloch, M, State, M, Pittenger, C. Recent advances in Tourette syndrome. Curr Opin Neurol 2011;24:119–25.Google Scholar

Cavanna, AE. Gilles de la Tourette syndrome. Neuropsychiatr News 2014;9:17–22.Google Scholar

Cavanna, AE, Seri, S. Tourette’s syndrome. Br Med J 2013;347:f4964.Google Scholar

Cavanna, AE, Shah, S. Update on Tourette syndrome. Psychiatr Times 2010;27:32–4.Google Scholar

Cavanna, AE, Termine, C. Tourette syndrome. Adv Exp Med Biol 2012;724:375–83.CrossRef Google Scholar PubMed

Coffey, BJ, Biederman, J, Geller, DA, Spencer, T, Park, KS, Shapiro, SJ, Garfield, SB. The course of Tourette’s disorder: A literature review. Harvard Rev Psychiatr 2000;8:192–8.Google Scholar

Dooley, JM. Tic disorders in childhood. Semin Pediatr Neurol 2006;13:231–42.CrossRef Google Scholar PubMed

Du, J-C, Chiu, T-F, Lee, K-M, Wu, H-L, Yang, Y-C, Hsu, S-Y, Sun, C-S, Hwang, B, Leckman, JF. Tourette syndrome in children: An updated review. Pediatr Neonatol 2010;51:255–64.Google Scholar

Efron, D, Dale, RC. Tics and Tourette syndrome. J Paediatr Child Health 2018;54:1148–53.Google Scholar

Galvez-Jimenez, N. Tics and Tourette syndrome: An adult perspective. Cleve Clin J Med 2012;79(Suppl 2):S35–9.Google Scholar PubMed

Ganos, C, Martino, D. Tics and Tourette syndrome. Neurol Clin 2015;33:115–36.CrossRef Google Scholar PubMed

Ganos, C, Munchau, A, Bhatia, KP. The semiology of tics, Tourette’s, and their associations. Mov Disord Clin Pract 2014;1:145–53.Google Scholar

Gilles de la Tourette, G. Étude sur une affection nerveuse caractérisée par de l’incoordination motrice accompagnée d’écholalie et de coprolalie. Arch Neurol 1885;9:19–42, 158–200.Google Scholar

Gravino, G. Gilles de la Tourette syndrome. Ann Clin Psychiatr 2013;25:297–306.Google Scholar

Gunduz, A, Okun, MS. A review and update on Tourette syndrome: Where is the field heading? Curr Neurol Neurosci Rep 2016;16:37.Google Scholar

Hallett, M. Tourette syndrome: Update. Brain Dev 2015;37:651–5.Google Scholar

Hartmann, A, Worbe, Y. Tourette syndrome: Clinical spectrum, mechanisms and personalized treatments. Curr Opin Neurol 2018;31:504–9.CrossRef Google Scholar PubMed

Hassan, N, Cavanna, AE. The prognosis of Tourette syndrome: Implications for clinical practice. Funct Neurol 2012;27:23–7.Google Scholar PubMed

Hirschtritt, ME, Dy, ME, Yang, KG, Scharf, JM. Diagnosis and treatment of Tourette syndrome. Neurology 2016;87:e65–7.Google Scholar

Itard, JMG. Mémoire sur quelques fonctions involontaires des appareils de la locomotion de la préhension et de la voix. Arch Gen Med 1825;8:385–407.Google Scholar

Jankovic, J, Kurlan, R. Tourette syndrome: Evolving concepts. Mov Disord 2011;26:1149–56.Google Scholar

Jankovic, J. Tourette’s syndrome. N Engl J Med 2001;345:1184–92.Google Scholar

Kenney, C, Kuo, SH, Jimenez-Shahed, J. Tourette’s syndrome. Am Fam Physician 2008;77:651–8.Google Scholar

Leckman, JF. Tourette’s syndrome. Lancet 2002;360:1577–86.Google Scholar

Martino, D, Ganos, C, Pringsheim, TM. Tourette syndrome and chronic tic disorders: The clinical spectrum beyond tics. Int Rev Neurobiol 2017;134:1461–90.Google Scholar

McNaught, KS, Mink, JW. Advances in understanding and treatment of Tourette syndrome. Nat Rev Neurol 2011;7:667–76.Google Scholar

Ong, MT, Mordekar, SR, Seal, A. 15 minute consultation: tics and Tourette syndrome. Arch Dis Child Educ Pract Ed 2016;101:87–94.Google Scholar

Plessen, KJ. Tic disorders and Tourette’s syndrome. Eur Child Adolesc Psychiatr 2013;22(Suppl 1):S55–60.Google Scholar

Pringsheim, T. Tourette syndrome and other tic disorders of childhood. Handb Clin Neurol 2013;112:853–6.Google Scholar

Rickards, H, Woolf, I, Cavanna, AE. Trousseau’s disease: a description of Gilles de la Tourette syndrome 12 years before 1885. Mov Disord 2010;25:2285–9.Google Scholar

Rickards, H. Tourette’s syndrome and other tic disorders. Pract Neurol 2010;10:252–9.Google Scholar

Rivera-Navarro, J, Cubo, E, Almazán, J. The diagnosis of Tourette’s syndrome: Communication and impact. Clin Child Psychol Psychiatr 2009;14:13–23.CrossRef Google Scholar PubMed

Robertson, MM, Eapen, V, Singer, HS, Martino, D, Scharf, JM, Paschou, P, Roessner, V, Woods, DW, Hariz, M, Mathews, CA, Crncec, R, Leckman, JF. Gilles de la Tourette syndrome. Nature Rev Dis Primers 2017;3:16097.Google Scholar

Robertson, MM. A personal 35 year perspective on Gilles de la Tourette syndrome: Prevalence, phenomenology, comorbidities, and coexistent psychopathologies. Lancet Psychiatr 2015;2:68–87.CrossRef Google Scholar PubMed

Robertson, MM. A personal 35 year perspective on Gilles de la Tourette syndrome: Assessment, investigations, and management. Lancet Psychiatr 2015;2:88–104.CrossRef Google Scholar PubMed

Robertson, MM. Gilles de la Tourette syndrome: The complexities of phenotype and treatment. Br J Hosp Med 2011;72:100–7.Google Scholar

Robertson, MM. The Gilles de la Tourette syndrome: The current status. Arch Dis Child Educ Pract Ed 2012;97:166–75.CrossRef Google Scholar PubMed

Robertson, MM. Tourette syndrome, associated conditions and the complexities of treatment. Brain 2000;123:425–62.Google Scholar

Roth, J. The colorful spectrum of Tourette syndrome and its medical, surgical and behavioral therapies. Parkinsonism Relat Disord 2018;46(Suppl 1):S75–9.CrossRef Google Scholar PubMed

Serajee, FJ, Mahbubul Huq, AH. Advances in Tourette syndrome: Diagnoses and treatment. Pediatr Clin North Am 2015;62:687–701.Google Scholar

Shprecher, DR, Kious, BM, Himle, M. Advances in mechanistic understanding and treatment approaches to Tourette syndrome. Discov Med 2015;20:295–301.Google Scholar

Shprecher, DR, Schrock, L, Himle, M. Neurobehavioral aspects, pathophysiology, and management of Tourette syndrome. Curr Opin Neurol 2014;27:484–92.Google Scholar

Singer, HS. Motor control, habits, complex motor stereotypies, and Tourette syndrome. Ann N Y Acad Sci 2013;1304:22–31.CrossRef Google Scholar PubMed

Singer, HS. Tourette syndrome and other tic disorders. Handb Clin Neurol 2011;100:641–57.Google Scholar

Singer, HS. Tourette’s syndrome: From behavior to biology. Lancet Neurol 2005;4:149–59.Google Scholar

Stern, JS, Burza, S, Robertson, MM. Gilles de la Tourette’s syndrome and its impact in the UK. Postgrad Med J 2005;81:12–19.Google Scholar

Stern, JS. Tourette’s syndrome and its borderland. Pract Neurol 2018;18:262–70.Google Scholar

Tagwerker Gloor, F, Walitza, S. Tic disorders and Tourette syndrome: Current concepts of etiology and treatment in children and adolescents. Neuropediatrics 2016;47:84–96.Google Scholar

Thenganatt, MA, Jankovic, J. Recent advances in understanding and managing Tourette syndrome. F1000Research 2016;5:152.Google Scholar

Trousseau, A. Des diverses espèces de chorées. Clinique Médicale de l’Hôtel Dieu. Paris 1873;2:264–71.Google Scholar

Black, KJ. Tourette syndrome research highlights from 2016. F1000Research 2017;6:1430.Google Scholar

Hartmann, A, Worbe, Y, Black, KJ. Tourette syndrome research highlights from 2017. F1000Research 2018;7:1122.Google Scholar

Mariam, N, Cavanna, AE. The most cited works in Tourette syndrome. J Child Neurol 2012;27:1250–9.Google Scholar

Richards, CA, Black, KJ. Tourette syndrome research highlights 2014. F1000Research 2015;4:69.Google Scholar

Richards, CA, Black, KJ. Tourette syndrome research highlights 2015. F1000Research 2016;5:1493.Google Scholar

Srirathan, H, Cavanna, AE. Research trends in the neuropsychiatry literature since the new millennium. J Neuropsychiatr Clin Neurosci 2015;27:354–61.Google Scholar

Cavanna, AE. Improved criteria for the diagnosis of tic disorders in DSM-5. Future Neurol 2014;9:251–3.Google Scholar

Knight, T, Steeves, T, Day, L, Lowerison, M, Jette, N, Pringsheim, T. Prevalence of tic disorders: A systematic review and meta-analysis. Pediatr Neurol 2012;47:77–90.Google Scholar

Robertson, MM, Eapen, V. Tourette’s: syndrome, disorder or spectrum? Classificatory challenges and an appraisal of the DSM criteria. Asian J Psychiatr 2014;11:106–13.Google Scholar

Robertson, MM. The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 1: The epidemiological and prevalence studies. J Psychosomatic Res 2008;65:461–72.Google Scholar